data_6m3n_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6m3n _Structure_validation_residue.Date_analyzed 2020-08-21 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.56 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.593 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.5 p-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE2' ' CZ ' ' A' ' 27' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.499 ' SD ' HG21 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.586 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.6 p-80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.862 0.363 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 55' ' ' LEU . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 80.4 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 29' ' ' ASP . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.488 ' HE2' ' HB3' ' A' ' 6' ' ' SER . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 6' ' ' SER . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 13.5 t . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.543 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.543 ' ND2' HG22 ' A' ' 9' ' ' THR . 28.2 p30 . . . . . 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 51.8 mp0 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.484 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 3.5 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.641 ' SD ' ' OG ' ' A' ' 6' ' ' SER . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.598 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.0 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 22' ' ' GLU . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.604 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 47.7 p-80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 88.6 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.77 0.319 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' CB ' ' HD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 9' ' ' THR . 3.0 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.556 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.584 ' SD ' ' NZ ' ' A' ' 51' ' ' LYS . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' NZ ' ' SD ' ' A' ' 48' ' ' MET . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.9 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HG3' ' HZ3' ' A' ' 56' ' ' LYS . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.508 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.591 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.583 HD22 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.596 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 62' ' ' ASN . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.647 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.5 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HG2' ' CZ3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' CE2' HG13 ' A' ' 63' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.559 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.48 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.589 ' SD ' HG22 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.508 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.511 HD13 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' O ' ' OG ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.589 HG22 ' SD ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 15.1 t . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.463 ' CG2' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.549 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.463 ' OD1' ' CG2' ' A' ' 9' ' ' THR . 34.3 m120 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.579 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HE2' ' CD1' ' A' ' 19' ' ' PHE . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.44 ' SD ' HG23 ' A' ' 63' ' ' VAL . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 6.8 m120 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.582 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.579 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD11 ' OG ' ' A' ' 6' ' ' SER . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 3' ' ' THR . 53.5 tp10 . . . . . 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.624 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.468 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.572 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.534 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.572 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.592 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.511 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 29' ' ' ASP . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.635 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.0 p-80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 . . . . . 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.92 0.39 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.492 HD21 ' CG2' ' A' ' 9' ' ' THR . 69.0 m-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.663 0.268 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' HG11 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' HG11 ' A' ' 44' ' ' VAL . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.513 ' HE3' ' OG ' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' NZ ' ' OG ' ' A' ' 6' ' ' SER . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HA ' HD11 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.609 ' CZ3' ' CA ' ' A' ' 22' ' ' GLU . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.422 ' C ' ' HH ' ' A' ' 32' ' ' TYR . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 66' ' ' GLU . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 55' ' ' LEU . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.555 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.715 ' SD ' ' CG ' ' A' ' 27' ' ' PHE . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.586 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.594 ' N ' ' OD2' ' A' ' 57' ' ' ASP . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD13 ' NZ ' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.579 HG13 ' CE2' ' A' ' 32' ' ' TYR . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 62' ' ' ASN . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.56 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.544 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 45' ' ' VAL . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.558 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.586 ' SD ' HG11 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.558 ' OD1' ' O ' ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.553 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.56 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.586 HG11 ' SD ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.543 ' OG ' ' HE1' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.651 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' A' ' 9' ' ' THR . 34.4 m120 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.647 0.26 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.592 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CE2' HG11 ' A' ' 63' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CE2' ' HE1' ' A' ' 65' ' ' HIS . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.566 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 29' ' ' ASP . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.62 ' CE ' ' CG2' ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' O ' ' OG ' ' A' ' 6' ' ' SER . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG2' ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.7 p-80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 120.77 0.319 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 8' ' ' VAL . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CE2' ' CD2' ' A' ' 19' ' ' PHE . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.516 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.573 ' SD ' HD23 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.556 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.517 ' OE1' ' HE3' ' A' ' 56' ' ' LYS . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.645 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.573 HD23 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.491 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.549 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 121.107 0.479 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.557 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 55' ' ' LEU . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.478 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 30' ' ' SER . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 32' ' ' TYR . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.562 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG2' ' O ' ' A' ' 41' ' ' PRO . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.551 ' N ' HG21 ' A' ' 44' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.594 ' SD ' HG23 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.594 HG23 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 13.0 t . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.631 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.559 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CD2' ' NE2' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.46 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.55 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' VAL . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.431 ' CE ' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 50' ' ' ALA . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.631 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.664 ' NE2' ' CD2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.473 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.46 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.647 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 p-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 31' ' ' ALA . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.575 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.553 HG23 ' CD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 29' ' ' ASP . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.586 ' SD ' HD22 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 57' ' ' ASP . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HA ' HG23 ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.586 HD22 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.698 0.285 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.509 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 9.8 mp0 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.518 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 30' ' ' SER . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 48' ' ' MET . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.664 ' CE ' ' CD2' ' A' ' 27' ' ' PHE . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.585 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.538 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.454 HD22 ' HE3' ' A' ' 51' ' ' LYS . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 55.7 p-80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.647 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' HG22 ' A' ' 9' ' ' THR . 81.9 m-20 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 47.3 mt-10 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 26' ' ' GLN . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.559 ' CD2' ' HE1' ' A' ' 19' ' ' PHE . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 32' ' ' TYR . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' A' ' 42' ' ' SER . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.482 ' CE ' ' HD2' ' A' ' 51' ' ' LYS . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.2 OUTLIER -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 54.2 p-80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.511 0.196 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.528 ' CB ' ' HD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 10' ' ' THR . 35.3 m120 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.584 ' CD2' HG22 ' A' ' 40' ' ' VAL . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 32' ' ' TYR . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' ASP . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.591 ' SD ' HG23 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.556 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 15.8 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.605 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.576 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.591 HG23 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.432 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 44' ' ' VAL . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.66 ' SD ' ' CG2' ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.66 ' CG2' ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.6 p30 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.492 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.478 ' HE1' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 32' ' ' TYR . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 12.2 t -116.2 150.98 36.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m -90.44 126.98 36.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.44 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.56 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.598 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.5 p-10 -161.83 44.5 0.14 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 33.1 Cg_endo -66.1 109.72 1.59 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.391 2.061 . . . . 0.0 112.124 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD2' ' C ' ' A' ' 13' ' ' ASP . 54.1 p30 -94.09 167.9 11.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.2 -14.21 16.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.099 0.476 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.52 -39.19 97.0 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.989 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.95 -166.55 17.82 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 53.0 p90 -110.73 113.3 25.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.542 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 -155.08 140.78 18.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.188 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE2' ' CZ ' ' A' ' 27' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.499 ' SD ' HG21 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.586 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.6 p-80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' O ' ' OG1' ' A' ' 2' ' ' THR . 89.0 tt0 -140.47 134.06 30.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.587 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.8 p -76.49 153.35 35.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m -117.08 128.72 55.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 55' ' ' LEU . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.602 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 27.3 p30 -161.77 44.08 0.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 40.9 Cg_endo -69.39 110.03 2.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.391 2.061 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 14' ' ' PHE . 37.6 t70 -83.7 120.93 26.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 11.2 m-30 70.57 -25.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 65.96 35.87 91.29 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -35.3 -97.42 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.647 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 25.5 p90 -129.33 95.73 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -155.26 144.49 20.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.943 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 29' ' ' ASP . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.488 ' HE2' ' HB3' ' A' ' 6' ' ' SER . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 6' ' ' SER . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 -118.32 135.12 54.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.557 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.14 130.94 57.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.507 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 13.5 t -126.87 145.8 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.543 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.543 ' ND2' HG22 ' A' ' 9' ' ' THR . 28.2 p30 -141.01 59.19 10.39 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 56.9 Cg_exo -51.02 118.53 4.34 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -125.74 135.95 52.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.0 -10.52 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.307 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.4 96.67 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.78 -170.37 14.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.638 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.2 p90 -96.34 115.9 28.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.8 mp0 -154.83 140.31 17.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.385 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 3.5 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.641 ' SD ' ' OG ' ' A' ' 6' ' ' SER . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.598 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.0 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 22' ' ' GLU . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.604 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 47.7 p-80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 88.6 tt0 -105.88 129.99 53.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.62 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.6 m -72.3 132.76 44.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.698 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -118.57 129.76 55.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' CB ' ' HD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 9' ' ' THR . 3.0 p-10 -144.12 63.13 11.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.0 117.52 3.97 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.804 2.336 . . . . 0.0 111.531 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -110.49 100.91 9.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.717 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.8 -33.68 72.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.65 -23.59 63.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.741 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.82 -173.62 16.3 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.6 p90 -105.59 115.74 30.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.15 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 -154.98 140.94 18.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.556 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.584 ' SD ' ' NZ ' ' A' ' 51' ' ' LYS . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' NZ ' ' SD ' ' A' ' 48' ' ' MET . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.9 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HG3' ' HZ3' ' A' ' 56' ' ' LYS . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.508 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.591 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.583 HD22 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.14 132.68 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.554 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mmm . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -74.37 152.9 39.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p -120.58 147.01 45.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.561 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.596 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 62' ' ' ASN . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.647 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.573 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t-20 -162.83 47.24 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.581 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 55.8 Cg_endo -72.81 109.88 2.9 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.751 2.301 . . . . 0.0 112.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -75.85 150.7 37.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.11 9.85 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.54 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.97 2.68 79.95 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.98 -176.13 21.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 55.5 p90 -101.3 117.68 35.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.52 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.5 mm-40 -155.65 142.61 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.955 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 12' ' ' PRO . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HG2' ' CZ3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.556 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' CE2' HG13 ' A' ' 63' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.559 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.589 ' SD ' HG22 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.508 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.511 HD13 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' O ' ' OG ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.589 HG22 ' SD ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 -99.13 128.86 45.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.591 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.611 ' CG ' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.611 ' N ' ' CG ' ' A' ' 1' ' ' MET . 95.2 m -113.29 131.13 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 15.1 t -128.26 147.73 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.463 ' CG2' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.549 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.463 ' OD1' ' CG2' ' A' ' 9' ' ' THR . 34.3 m120 -133.94 72.02 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 24.6 Cg_endo -63.58 111.79 1.59 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.147 1.898 . . . . 0.0 111.527 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -129.45 139.93 51.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.57 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.04 -14.31 15.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.86 96.81 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.76 -168.18 17.33 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.5 p90 -102.89 112.51 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.425 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.494 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 79.0 mm-40 -155.07 142.42 19.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.117 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.579 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HE2' ' CD1' ' A' ' 19' ' ' PHE . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.44 ' SD ' HG23 ' A' ' 63' ' ' VAL . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 6.8 m120 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.582 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.579 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD11 ' OG ' ' A' ' 6' ' ' SER . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 HG23 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 3' ' ' THR . 53.5 tp10 -114.71 133.58 55.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.519 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.8 m -115.25 128.23 56.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m -118.39 129.2 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.624 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -144.17 60.51 8.03 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 60.4 Cg_exo -51.58 122.32 10.07 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.115 1.877 . . . . 0.0 110.922 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 15' ' ' GLY . 67.5 t0 -122.77 111.39 16.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.526 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -73.75 -25.37 60.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.459 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -59.42 -39.86 95.37 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.415 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.3 -171.16 17.13 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 50.8 p90 -100.96 114.82 29.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.195 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 -155.21 141.75 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.534 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.592 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.511 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 29' ' ' ASP . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.635 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.0 p-80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 -115.37 134.6 54.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.554 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 67' ' ' ALA . 62.0 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.24 128.56 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.455 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m -118.81 129.14 55.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.492 HD21 ' CG2' ' A' ' 9' ' ' THR . 69.0 m-80 -143.67 73.44 17.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.87 113.25 1.49 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.408 2.072 . . . . 0.0 111.498 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -122.9 136.56 54.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.611 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.07 -17.54 14.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 0.0 110.721 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.72 -40.3 97.87 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.92 -167.68 22.37 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 49.3 p90 -104.22 109.96 21.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.966 0.412 . . . . 0.0 110.223 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.0 mp0 -154.76 140.1 17.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.453 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 30' ' ' SER . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' HG11 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' HG11 ' A' ' 44' ' ' VAL . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.513 ' HE3' ' OG ' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' NZ ' ' OG ' ' A' ' 6' ' ' SER . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HA ' HD11 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.609 ' CZ3' ' CA ' ' A' ' 22' ' ' GLU . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.422 ' C ' ' HH ' ' A' ' 32' ' ' TYR . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 -138.81 137.89 37.05 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.574 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.3 m -115.18 129.67 56.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.326 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m -119.02 129.36 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 66' ' ' GLU . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 55' ' ' LEU . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 34.4 m120 -137.02 64.76 49.85 Favored Pre-proline 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 53.2 Cg_exo -52.69 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.241 1.961 . . . . 0.0 111.547 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -122.43 132.51 54.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.409 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.23 -21.59 13.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.592 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.25 97.28 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.91 -169.88 21.62 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 46.1 p90 -98.99 109.7 22.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.483 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 50.9 mp0 -154.99 142.28 19.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.555 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.715 ' SD ' ' CG ' ' A' ' 27' ' ' PHE . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.586 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.594 ' N ' ' OD2' ' A' ' 57' ' ' ASP . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD13 ' NZ ' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.579 HG13 ' CE2' ' A' ' 32' ' ' TYR . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 -110.01 138.29 46.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.591 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -70.36 134.44 47.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.485 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m -117.81 129.38 55.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 62' ' ' ASN . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.56 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.613 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 5.6 p-10 -160.45 44.38 0.16 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 55.2 Cg_endo -70.34 112.42 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.641 2.228 . . . . 0.0 112.231 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.37 162.84 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.596 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -101.46 5.89 42.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.106 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.88 -39.65 98.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.66 -160.31 10.52 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 52.8 p90 -101.72 120.18 39.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 -154.75 141.19 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.558 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.544 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 45' ' ' VAL . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.558 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.586 ' SD ' HG11 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' OD1' ' O ' ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.553 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.56 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.586 HG11 ' SD ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -102.22 129.58 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.575 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -80.9 153.45 27.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p -119.74 145.53 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.643 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.543 ' OG ' ' HE1' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.651 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' A' ' 9' ' ' THR . 34.4 m120 -135.43 71.65 66.05 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.97 113.3 1.81 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.1 1.867 . . . . 0.0 111.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 14' ' ' PHE . 58.5 t0 -131.15 139.2 49.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.506 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 98.6 m-85 -103.67 -5.26 22.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.761 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.61 95.81 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.02 -177.75 15.15 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 54.7 p90 -87.55 116.18 25.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 0.0 110.067 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 -154.82 139.69 17.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.318 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.592 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CE2' HG11 ' A' ' 63' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CE2' ' HE1' ' A' ' 65' ' ' HIS . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.566 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 29' ' ' ASP . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.62 ' CE ' ' CG2' ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' O ' ' OG ' ' A' ' 6' ' ' SER . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG2' ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.7 p-80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -96.31 127.83 42.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.587 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ptp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.174 0.511 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -73.93 152.83 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.648 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -117.13 127.76 54.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.47 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 8' ' ' VAL . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 -155.16 56.14 1.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 92.5 Cg_exo -39.26 110.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.795 2.33 . . . . 0.0 111.725 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -112.96 133.99 54.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.621 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.85 -3.96 24.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.68 95.91 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.64 177.47 17.51 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.82 103.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.83 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 98.4 mt-10 -151.24 138.16 19.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CE2' ' CD2' ' A' ' 19' ' ' PHE . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.516 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.573 ' SD ' HD23 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.556 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' OE1' ' HE3' ' A' ' 56' ' ' LYS . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.645 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.573 HD23 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.491 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.549 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 -92.91 129.71 38.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.598 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.7 m -115.03 131.36 56.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.465 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t -128.13 147.62 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.557 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 55' ' ' LEU . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -161.22 67.72 2.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.96 109.18 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.863 2.375 . . . . 0.0 111.576 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.473 ' CG ' ' HD1' ' A' ' 14' ' ' PHE . 58.3 p30 -132.86 159.66 39.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.896 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 96.9 m-85 63.04 95.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.449 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.93 69.39 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PHE . . . -122.96 -154.24 8.99 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 50.3 p90 -86.2 107.15 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.502 . . . . 0.0 110.301 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -154.91 141.46 18.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.671 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.478 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 30' ' ' SER . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.605 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 32' ' ' TYR . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.562 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG2' ' O ' ' A' ' 41' ' ' PRO . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.551 ' N ' HG21 ' A' ' 44' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.594 ' SD ' HG23 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.594 HG23 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -101.77 128.98 47.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.602 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.1 m -115.32 130.95 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 13.0 t -126.42 147.4 49.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.673 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.631 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 34.4 m120 -146.04 45.54 0.48 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 57.5 Cg_endo -73.26 112.6 3.57 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.633 2.222 . . . . 0.0 111.971 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -106.51 164.46 12.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -99.06 9.51 43.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.463 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.91 7.31 58.95 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.22 -177.18 24.79 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.631 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.4 p90 -111.23 114.62 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.005 0.431 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 -155.63 141.93 18.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.559 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CD2' ' NE2' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.46 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.55 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' VAL . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.431 ' CE ' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 50' ' ' ALA . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.631 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.664 ' NE2' ' CD2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.07 127.99 53.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.539 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -115.29 128.33 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m -118.81 129.46 55.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.039 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.473 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.46 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.647 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.2 p-10 -162.1 43.52 0.11 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 46.4 Cg_endo -70.39 110.13 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.454 2.103 . . . . 0.0 112.518 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.79 157.54 23.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.789 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -100.52 13.43 34.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.14 4.6 81.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.41 -178.82 30.03 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 53.6 p90 -97.38 119.11 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 -155.57 142.29 18.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 31' ' ' ALA . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 HG23 ' CD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 29' ' ' ASP . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.586 ' SD ' HD22 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 57' ' ' ASP . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HA ' HG23 ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.586 HD22 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -105.18 130.81 53.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.535 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.23 131.0 57.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p -121.93 147.98 45.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.509 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.07 58.66 5.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HG3' ' NE1' ' A' ' 60' ' ' TRP . 58.6 Cg_endo -74.44 121.24 6.64 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.383 2.056 . . . . 0.0 110.751 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -131.89 166.45 21.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -104.73 18.75 21.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.512 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.07 20.14 29.04 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.08 -175.56 36.58 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 40.5 p90 -121.75 110.19 15.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 110.128 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 9.8 mp0 -154.93 145.87 22.59 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.518 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' ALA . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 30' ' ' SER . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 48' ' ' MET . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.664 ' CE ' ' CD2' ' A' ' 27' ' ' PHE . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.585 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.538 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.454 HD22 ' HE3' ' A' ' 51' ' ' LYS . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 55.7 p-80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 -109.99 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.557 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.579 HG23 ' CE2' ' A' ' 4' ' ' PHE . 93.7 m -71.26 133.24 45.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.474 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m -116.21 129.06 56.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE2' HG23 ' A' ' 2' ' ' THR . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.647 ' CB ' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 81.9 m-20 -134.73 62.24 52.66 Favored Pre-proline 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 44.2 Cg_exo -55.45 118.03 4.71 Favored 'Trans proline' 0 C--N 1.297 -2.144 0 C-N-CA 122.314 2.01 . . . . 0.0 111.168 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 55.9 p-10 -125.68 95.22 4.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.0 -36.26 83.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.12 95.81 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.53 -167.06 40.5 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 33.5 p90 -120.02 104.17 9.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.956 0.408 . . . . 0.0 109.986 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 47.3 mt-10 -155.94 146.09 21.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.821 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 26' ' ' GLN . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.559 ' CD2' ' HE1' ' A' ' 19' ' ' PHE . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 32' ' ' TYR . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' A' ' 42' ' ' SER . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.482 ' CE ' ' HD2' ' A' ' 51' ' ' LYS . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.2 OUTLIER -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 54.2 p-80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' ALA . 89.0 tt0 -132.89 137.62 46.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.3 130.43 56.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.486 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p -124.39 148.18 47.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.494 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.528 ' CB ' ' HD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.621 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 35.3 m120 -158.35 43.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 48.6 Cg_endo -70.91 112.26 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.574 2.183 . . . . 0.0 112.217 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -92.02 165.45 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.606 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -101.1 10.85 40.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.44 72.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.39 -178.21 28.55 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 51.7 p90 -103.92 118.43 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.964 0.411 . . . . 0.0 110.36 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 -155.12 142.51 19.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.887 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.584 ' CD2' HG22 ' A' ' 40' ' ' VAL . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 32' ' ' TYR . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' ASP . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.591 ' SD ' HG23 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.556 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 15.8 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.605 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.576 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.591 HG23 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -89.7 128.16 36.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.482 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.2 m -114.5 128.5 56.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.595 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m -119.25 128.46 54.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -133.06 63.95 68.68 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 20.3 Cg_endo -61.78 114.7 2.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.552 2.168 . . . . 0.0 111.312 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.06 136.46 52.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.804 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.51 9.42 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.577 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.39 5.02 77.51 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.42 -176.61 31.68 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 52.9 p90 -102.54 118.55 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 -155.65 142.49 18.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.943 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.432 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 44' ' ' VAL . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.66 ' SD ' ' CG2' ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.66 ' CG2' ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -84.84 124.41 31.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.34 130.57 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.343 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -128.16 147.8 50.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.607 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 28.6 p30 -161.68 43.92 0.13 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 37.3 Cg_endo -67.82 111.66 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.443 2.095 . . . . 0.0 112.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 54.4 p30 -91.41 167.21 12.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.692 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.04 16.0 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.722 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.36 2.89 81.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.74 -178.66 33.94 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.6 p90 -98.24 119.72 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.011 0.434 . . . . 0.0 110.4 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 -155.26 140.4 17.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.518 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.492 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.478 ' HE1' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 32' ' ' TYR . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -105.77 130.3 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.593 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.5 p-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.907 ' HD1' ' HH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.859 ' HB3' HG21 ' A' ' 45' ' ' VAL . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.907 ' HH ' ' HD1' ' A' ' 19' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.484 ' HB2' HG22 ' A' ' 38' ' ' VAL . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 32' ' ' TYR . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.62 ' HB2' HD22 ' A' ' 61' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 52' ' ' ALA . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.608 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.714 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.7 p80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.862 0.363 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.935 HG21 ' O ' ' A' ' 58' ' ' GLY . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 80.4 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 36' ' ' TYR . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 48' ' ' MET . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 40' ' ' VAL . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' SER . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.451 ' SD ' HG22 ' A' ' 63' ' ' VAL . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.935 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.626 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 48' ' ' MET . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.5 t . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.536 HG21 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.536 ' ND2' HG21 ' A' ' 9' ' ' THR . 28.2 p30 . . . . . 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 51.8 mp0 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 17.7 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.646 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.837 ' HE2' ' HE2' ' A' ' 51' ' ' LYS . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.703 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.837 ' HE2' ' HE2' ' A' ' 48' ' ' MET . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' NE2' ' A' ' 54' ' ' GLN . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.703 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 11.7 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 52' ' ' ALA . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.552 ' N ' ' HB ' ' A' ' 10' ' ' THR . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 12.4 p80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.779 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.6 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.77 0.319 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.614 HG23 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.614 ' OD1' HG23 ' A' ' 9' ' ' THR . 3.0 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 30' ' ' SER . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 36' ' ' TYR . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.844 HG12 ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 61' ' ' LEU . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.844 ' OD1' HG12 ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.425 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 9.4 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.832 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.612 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' HD11 ' A' ' 61' ' ' LEU . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.082 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.5 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 21' ' ' VAL . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.561 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.817 HG12 ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.819 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.817 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 52' ' ' ALA . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 1.082 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.646 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.819 HG13 ' CE ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 66' ' ' GLU . 15.1 t . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.635 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.525 HG23 ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.525 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.3 m120 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HE2' ' CD1' ' A' ' 19' ' ' PHE . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.54 HG23 HG12 ' A' ' 40' ' ' VAL . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 6' ' ' SER . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 52' ' ' ALA . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' HD11 ' A' ' 55' ' ' LEU . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.623 ' HB3' HG22 ' A' ' 3' ' ' THR . 53.5 tp10 . . . . . 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.1 p30 . . . . . 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.536 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 40' ' ' VAL . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 52' ' ' ALA . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.742 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.679 ' HB3' ' HH ' ' A' ' 32' ' ' TYR . 11.9 p80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 . . . . . 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.92 0.39 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.813 ' O ' HD13 ' A' ' 7' ' ' ILE . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.788 HG23 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 m120 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.663 0.268 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.642 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 29' ' ' ASP . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 61' ' ' LEU . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 52' ' ' ALA . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.788 ' CD1' HG23 ' A' ' 10' ' ' THR . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 51' ' ' LYS . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' A' ' 27' ' ' PHE . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.764 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.447 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.546 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.428 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG12 ' CE ' ' A' ' 48' ' ' MET . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.718 ' CE ' HG12 ' A' ' 44' ' ' VAL . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.663 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.764 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 36' ' ' TYR . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.778 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' PRO . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.755 HG12 ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 1.009 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.755 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HB2' HD22 ' A' ' 61' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.767 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 52' ' ' ALA . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.722 ' O ' HG21 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.571 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' A' ' 51' ' ' LYS . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.009 HG13 ' CE ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.447 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.647 0.26 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 45' ' ' VAL . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 40' ' ' VAL . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 1.093 ' CE ' HG22 ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.565 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 51' ' ' LYS . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HE1' ' A' ' 20' ' ' TYR . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.093 HG22 ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.2 p80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 120.77 0.319 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.872 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.603 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 45' ' ' VAL . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.658 ' HA ' HG12 ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 27' ' ' PHE . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.598 ' ND2' HG22 ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.872 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.738 ' HD1' ' HG1' ' A' ' 10' ' ' THR . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG22 ' SD ' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.495 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.552 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 121.107 0.479 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 44' ' ' VAL . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.898 ' OG ' HD11 ' A' ' 61' ' ' LEU . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.577 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' N ' HG23 ' A' ' 7' ' ' ILE . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 4' ' ' PHE . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 40' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.68 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.898 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.533 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.0 t . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.613 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.912 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.672 ' HB3' HG21 ' A' ' 45' ' ' VAL . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.66 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.864 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 32' ' ' TYR . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HG3' ' HE3' ' A' ' 48' ' ' MET . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.634 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 52' ' ' ALA . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.912 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD21 ' SD ' ' A' ' 48' ' ' MET . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.864 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.9 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.535 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.946 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 p-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.472 HG12 ' ND2' ' A' ' 49' ' ' ASN . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.644 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.946 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' CG ' ' CE2' ' A' ' 20' ' ' TYR . 46.0 t30 -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.698 0.285 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 9.8 mp0 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 45' ' ' VAL . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 38' ' ' VAL . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 29' ' ' ASP . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.913 ' HE1' HG21 ' A' ' 63' ' ' VAL . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 52' ' ' ALA . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.55 ' N ' ' HB ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 61' ' ' LEU . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.913 HG21 ' HE1' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 14.2 p80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.1 m120 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 47.3 mt-10 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.626 HG13 ' OE1' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.626 ' OE1' HG13 ' A' ' 21' ' ' VAL . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CD1' HG23 ' A' ' 45' ' ' VAL . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 34' ' ' GLU . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.557 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 27' ' ' PHE . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.581 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.902 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.902 HD12 ' HA ' ' A' ' 52' ' ' ALA . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 55' ' ' LEU . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 8.9 t-20 -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.7 p80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.511 0.196 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.938 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.63 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HE1' ' A' ' 36' ' ' TYR . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 4' ' ' PHE . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.822 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.64 ' HD3' ' HE1' ' A' ' 48' ' ' MET . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.4 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.938 ' O ' HG21 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.702 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.822 HG22 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.027 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.1 m120 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 36' ' ' TYR . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' HD1' ' A' ' 27' ' ' PHE . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.853 ' SD ' HG22 ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.954 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' A' ' 52' ' ' ALA . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 1.027 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.853 HG22 ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.6 p30 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 45' ' ' VAL . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 39' ' ' SER . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.919 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 52' ' ' ALA . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 12.2 t -116.2 150.98 36.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m -90.44 126.98 36.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.44 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.598 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.5 p-10 -161.83 44.5 0.14 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 33.1 Cg_endo -66.1 109.72 1.59 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.391 2.061 . . . . 0.0 112.124 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD2' ' C ' ' A' ' 13' ' ' ASP . 54.1 p30 -94.09 167.9 11.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.2 -14.21 16.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.099 0.476 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.52 -39.19 97.0 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.989 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.95 -166.55 17.82 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 53.0 p90 -110.73 113.3 25.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.542 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 -155.08 140.78 18.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.188 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.907 ' HD1' ' HH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.859 ' HB3' HG21 ' A' ' 45' ' ' VAL . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.907 ' HH ' ' HD1' ' A' ' 19' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.484 ' HB2' HG22 ' A' ' 38' ' ' VAL . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 32' ' ' TYR . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.62 ' HB2' HD22 ' A' ' 61' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 52' ' ' ALA . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.608 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.714 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.7 p80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.567 ' O ' ' OG1' ' A' ' 2' ' ' THR . 89.0 tt0 -140.47 134.06 30.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.587 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.8 p -76.49 153.35 35.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m -117.08 128.72 55.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.935 HG21 ' O ' ' A' ' 58' ' ' GLY . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.602 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 27.3 p30 -161.77 44.08 0.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 40.9 Cg_endo -69.39 110.03 2.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.391 2.061 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 14' ' ' PHE . 37.6 t70 -83.7 120.93 26.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 11.2 m-30 70.57 -25.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 65.96 35.87 91.29 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -35.3 -97.42 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.647 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 25.5 p90 -129.33 95.73 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -155.26 144.49 20.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.943 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 36' ' ' TYR . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 48' ' ' MET . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 40' ' ' VAL . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' SER . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.451 ' SD ' HG22 ' A' ' 63' ' ' VAL . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.935 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.626 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 48' ' ' MET . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 -118.32 135.12 54.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.557 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.14 130.94 57.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.507 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.5 t -126.87 145.8 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.536 HG21 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.545 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 28.2 p30 -141.01 59.19 10.39 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 56.9 Cg_exo -51.02 118.53 4.34 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -125.74 135.95 52.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.0 -10.52 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.307 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.4 96.67 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.78 -170.37 14.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.638 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.2 p90 -96.34 115.9 28.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.8 mp0 -154.83 140.31 17.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.385 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 17.7 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.646 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.837 ' HE2' ' HE2' ' A' ' 51' ' ' LYS . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.703 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.837 ' HE2' ' HE2' ' A' ' 48' ' ' MET . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' NE2' ' A' ' 54' ' ' GLN . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.703 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 11.7 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 52' ' ' ALA . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.552 ' N ' ' HB ' ' A' ' 10' ' ' THR . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 12.4 p80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.779 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.6 tt0 -105.88 129.99 53.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.62 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.6 m -72.3 132.76 44.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.698 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -118.57 129.76 55.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.614 HG23 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.614 ' OD1' HG23 ' A' ' 9' ' ' THR . 3.0 p-10 -144.12 63.13 11.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 10.3 Cg_endo -54.0 117.52 3.97 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.804 2.336 . . . . 0.0 111.531 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -110.49 100.91 9.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.717 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.8 -33.68 72.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.65 -23.59 63.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.741 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.82 -173.62 16.3 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.6 p90 -105.59 115.74 30.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.15 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 -154.98 140.94 18.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 30' ' ' SER . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 36' ' ' TYR . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.844 HG12 ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 61' ' ' LEU . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.844 ' OD1' HG12 ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 9.4 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.832 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.612 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.14 132.68 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.554 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mmm . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -74.37 152.9 39.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p -120.58 147.01 45.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.561 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' HD11 ' A' ' 61' ' ' LEU . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.082 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.573 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t-20 -162.83 47.24 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 55.8 Cg_endo -72.81 109.88 2.9 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.751 2.301 . . . . 0.0 112.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -75.85 150.7 37.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.11 9.85 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.54 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.97 2.68 79.95 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.98 -176.13 21.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 55.5 p90 -101.3 117.68 35.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.5 mm-40 -155.65 142.61 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.955 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 12' ' ' PRO . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 21' ' ' VAL . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.561 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.817 HG12 ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.819 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.817 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 52' ' ' ALA . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 1.082 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.646 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.819 HG13 ' CE ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 -99.13 128.86 45.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.591 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.865 ' HG3' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.865 ' N ' ' HG3' ' A' ' 1' ' ' MET . 95.2 m -113.29 131.13 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 66' ' ' GLU . 15.1 t -128.26 147.73 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.635 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.525 HG23 ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.525 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.3 m120 -133.94 72.02 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 24.6 Cg_endo -63.58 111.79 1.59 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.147 1.898 . . . . 0.0 111.527 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -129.45 139.93 51.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.57 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.04 -14.31 15.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.86 96.81 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.76 -168.18 17.33 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.5 p90 -102.89 112.51 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.425 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 79.0 mm-40 -155.07 142.42 19.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.117 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HE2' ' CD1' ' A' ' 19' ' ' PHE . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.54 HG23 HG12 ' A' ' 40' ' ' VAL . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 6' ' ' SER . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 52' ' ' ALA . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' HD11 ' A' ' 55' ' ' LEU . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.623 ' HB3' HG22 ' A' ' 3' ' ' THR . 53.5 tp10 -114.71 133.58 55.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.519 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 1' ' ' MET . 27.4 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.8 m -115.25 128.23 56.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m -118.39 129.2 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 45.1 p30 -144.17 60.51 8.03 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 60.4 Cg_exo -51.58 122.32 10.07 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.115 1.877 . . . . 0.0 110.922 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 15' ' ' GLY . 67.5 t0 -122.77 111.39 16.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.526 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -73.75 -25.37 60.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.459 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -59.42 -39.86 95.37 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.415 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.3 -171.16 17.13 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 50.8 p90 -100.96 114.82 29.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.195 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 -155.21 141.75 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.536 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 40' ' ' VAL . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 52' ' ' ALA . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.742 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.679 ' HB3' ' HH ' ' A' ' 32' ' ' TYR . 11.9 p80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 -115.37 134.6 54.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.554 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 67' ' ' ALA . 62.0 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.24 128.56 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.455 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m -118.81 129.14 55.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.813 ' O ' HD13 ' A' ' 7' ' ' ILE . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.788 HG23 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -143.67 73.44 17.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.87 113.25 1.49 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.408 2.072 . . . . 0.0 111.498 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -122.9 136.56 54.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.611 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.07 -17.54 14.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 0.0 110.721 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.72 -40.3 97.87 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.92 -167.68 22.37 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 49.3 p90 -104.22 109.96 21.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.966 0.412 . . . . 0.0 110.223 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.0 mp0 -154.76 140.1 17.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.453 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.642 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 29' ' ' ASP . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 61' ' ' LEU . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 52' ' ' ALA . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.788 ' CD1' HG23 ' A' ' 10' ' ' THR . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 51' ' ' LYS . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' A' ' 27' ' ' PHE . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 -138.81 137.89 37.05 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.574 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' H3 ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.3 m -115.18 129.67 56.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.326 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m -119.02 129.36 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.764 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.447 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 -137.02 64.76 49.85 Favored Pre-proline 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 53.2 Cg_exo -52.69 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.241 1.961 . . . . 0.0 111.547 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -122.43 132.51 54.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.409 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.23 -21.59 13.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.592 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.25 97.28 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.91 -169.88 21.62 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 46.1 p90 -98.99 109.7 22.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.483 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 50.9 mp0 -154.99 142.28 19.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.546 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.428 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG12 ' CE ' ' A' ' 48' ' ' MET . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.718 ' CE ' HG12 ' A' ' 44' ' ' VAL . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.663 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.764 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 -110.01 138.29 46.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.591 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -70.36 134.44 47.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.485 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m -117.81 129.38 55.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.613 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 5.6 p-10 -160.45 44.38 0.16 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.625 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 55.2 Cg_endo -70.34 112.42 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.641 2.228 . . . . 0.0 112.231 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.37 162.84 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.596 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -101.46 5.89 42.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.106 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.88 -39.65 98.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.66 -160.31 10.52 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 52.8 p90 -101.72 120.18 39.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.0 mt-10 -154.75 141.19 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.558 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 36' ' ' TYR . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.778 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' PRO . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.755 HG12 ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 1.009 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.755 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HB2' HD22 ' A' ' 61' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.767 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 52' ' ' ALA . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.722 ' O ' HG21 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.571 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' A' ' 51' ' ' LYS . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.009 HG13 ' CE ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -102.22 129.58 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.575 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -80.9 153.45 27.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p -119.74 145.53 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.643 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.447 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 -135.43 71.65 66.05 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.97 113.3 1.81 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.1 1.867 . . . . 0.0 111.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 14' ' ' PHE . 58.5 t0 -131.15 139.2 49.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.506 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 98.6 m-85 -103.67 -5.26 22.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.761 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.61 95.81 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.02 -177.75 15.15 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 54.7 p90 -87.55 116.18 25.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 0.0 110.067 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 99.0 mt-10 -154.82 139.69 17.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.318 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 45' ' ' VAL . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 40' ' ' VAL . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 1.093 ' CE ' HG22 ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.565 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 51' ' ' LYS . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HE1' ' A' ' 20' ' ' TYR . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.093 HG22 ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.2 p80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -96.31 127.83 42.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.587 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ptp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.174 0.511 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -73.93 152.83 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.648 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -117.13 127.76 54.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.47 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.872 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.603 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 -155.16 56.14 1.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 92.5 Cg_exo -39.26 110.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.795 2.33 . . . . 0.0 111.725 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -112.96 133.99 54.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.621 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.85 -3.96 24.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.68 95.91 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.64 177.47 17.51 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.82 103.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.83 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 98.4 mt-10 -151.24 138.16 19.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 45' ' ' VAL . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.658 ' HA ' HG12 ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 27' ' ' PHE . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.598 ' ND2' HG22 ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.872 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.738 ' HD1' ' HG1' ' A' ' 10' ' ' THR . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG22 ' SD ' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.495 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.552 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 -92.91 129.71 38.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.598 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.7 m -115.03 131.36 56.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.465 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t -128.13 147.62 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 44' ' ' VAL . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.898 ' OG ' HD11 ' A' ' 61' ' ' LEU . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' N ' HG23 ' A' ' 7' ' ' ILE . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -161.22 67.72 2.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.96 109.18 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.863 2.375 . . . . 0.0 111.576 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' CG ' ' HD1' ' A' ' 14' ' ' PHE . 58.3 p30 -132.86 159.66 39.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.896 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 96.9 m-85 63.04 95.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.449 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.93 69.39 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PHE . . . -122.96 -154.24 8.99 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 50.3 p90 -86.2 107.15 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.502 . . . . 0.0 110.301 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -154.91 141.46 18.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.671 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 4' ' ' PHE . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 40' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.68 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.898 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.533 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -101.77 128.98 47.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.602 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.1 m -115.32 130.95 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.0 t -126.42 147.4 49.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.673 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.613 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.912 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 34.4 m120 -146.04 45.54 0.48 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 57.5 Cg_endo -73.26 112.6 3.57 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.633 2.222 . . . . 0.0 111.971 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -106.51 164.46 12.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -99.06 9.51 43.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.463 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.91 7.31 58.95 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.22 -177.18 24.79 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.631 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.4 p90 -111.23 114.62 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.005 0.431 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 -155.63 141.93 18.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.672 ' HB3' HG21 ' A' ' 45' ' ' VAL . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.66 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.864 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 32' ' ' TYR . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HG3' ' HE3' ' A' ' 48' ' ' MET . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.634 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 52' ' ' ALA . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.912 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD21 ' SD ' ' A' ' 48' ' ' MET . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.864 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.9 tt0 -106.07 127.99 53.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.539 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -115.29 128.33 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m -118.81 129.46 55.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.039 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.535 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.946 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.2 p-10 -162.1 43.52 0.11 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 46.4 Cg_endo -70.39 110.13 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.454 2.103 . . . . 0.0 112.518 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.79 157.54 23.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.789 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -100.52 13.43 34.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.14 4.6 81.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.41 -178.82 30.03 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 53.6 p90 -97.38 119.11 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 -155.57 142.29 18.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.472 HG12 ' ND2' ' A' ' 49' ' ' ASN . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.644 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.946 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' CG ' ' CE2' ' A' ' 20' ' ' TYR . 46.0 t30 -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -105.18 130.81 53.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.535 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.23 131.0 57.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p -121.93 147.98 45.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.07 58.66 5.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HG3' ' NE1' ' A' ' 60' ' ' TRP . 58.6 Cg_endo -74.44 121.24 6.64 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.383 2.056 . . . . 0.0 110.751 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -131.89 166.45 21.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -104.73 18.75 21.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.512 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.07 20.14 29.04 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.08 -175.56 36.58 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 40.5 p90 -121.75 110.19 15.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 110.128 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 9.8 mp0 -154.93 145.87 22.59 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 45' ' ' VAL . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 38' ' ' VAL . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 29' ' ' ASP . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.913 ' HE1' HG21 ' A' ' 63' ' ' VAL . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 52' ' ' ALA . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.55 ' N ' ' HB ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 61' ' ' LEU . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.913 HG21 ' HE1' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 14.2 p80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 -109.99 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.557 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 93.7 m -71.26 133.24 45.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.474 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m -116.21 129.06 56.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 25.1 m120 -134.73 62.24 52.66 Favored Pre-proline 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 44.2 Cg_exo -55.45 118.03 4.71 Favored 'Trans proline' 0 C--N 1.297 -2.144 0 C-N-CA 122.314 2.01 . . . . 0.0 111.168 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 55.9 p-10 -125.68 95.22 4.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.0 -36.26 83.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.12 95.81 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.53 -167.06 40.5 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 33.5 p90 -120.02 104.17 9.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.956 0.408 . . . . 0.0 109.986 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' OE2' ' OD2' ' A' ' 13' ' ' ASP . 47.3 mt-10 -155.94 146.09 21.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.821 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.626 HG13 ' OE1' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.626 ' OE1' HG13 ' A' ' 21' ' ' VAL . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CD1' HG23 ' A' ' 45' ' ' VAL . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 34' ' ' GLU . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.557 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 27' ' ' PHE . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.581 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.902 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.902 HD12 ' HA ' ' A' ' 52' ' ' ALA . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 55' ' ' LEU . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 8.9 t-20 -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 13.7 p80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' ALA . 89.0 tt0 -132.89 137.62 46.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.3 130.43 56.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.486 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p -124.39 148.18 47.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.494 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.938 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.621 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 73.4 m-80 -158.35 43.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 48.6 Cg_endo -70.91 112.26 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.574 2.183 . . . . 0.0 112.217 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -92.02 165.45 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.606 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -101.1 10.85 40.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.44 72.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.39 -178.21 28.55 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 51.7 p90 -103.92 118.43 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.964 0.411 . . . . 0.0 110.36 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 -155.12 142.51 19.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.887 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.63 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HE1' ' A' ' 36' ' ' TYR . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 4' ' ' PHE . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.822 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.64 ' HD3' ' HE1' ' A' ' 48' ' ' MET . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.4 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.938 ' O ' HG21 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.702 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.822 HG22 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -89.7 128.16 36.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.482 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.2 m -114.5 128.5 56.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.595 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m -119.25 128.46 54.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.027 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -133.06 63.95 68.68 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 20.3 Cg_endo -61.78 114.7 2.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.552 2.168 . . . . 0.0 111.312 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.06 136.46 52.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.804 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.51 9.42 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.577 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.39 5.02 77.51 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.42 -176.61 31.68 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 52.9 p90 -102.54 118.55 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 -155.65 142.49 18.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.943 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 36' ' ' TYR . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' HD1' ' A' ' 27' ' ' PHE . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.853 ' SD ' HG22 ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.954 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' A' ' 52' ' ' ALA . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 1.027 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.853 HG22 ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -84.84 124.41 31.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.34 130.57 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.343 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -128.16 147.8 50.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.607 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 28.6 p30 -161.68 43.92 0.13 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HB3' ' CD1' ' A' ' 20' ' ' TYR . 37.3 Cg_endo -67.82 111.66 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.443 2.095 . . . . 0.0 112.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 54.4 p30 -91.41 167.21 12.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.692 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.04 16.0 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.722 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.36 2.89 81.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.74 -178.66 33.94 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.6 p90 -98.24 119.72 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.011 0.434 . . . . 0.0 110.4 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 -155.26 140.4 17.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 45' ' ' VAL . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 39' ' ' SER . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.919 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 52' ' ' ALA . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -105.77 130.3 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.127 0.489 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.593 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.5 p-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.907 ' HD1' ' HH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.859 ' HB3' HG21 ' A' ' 45' ' ' VAL . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.907 ' HH ' ' HD1' ' A' ' 19' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 32' ' ' TYR . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.62 ' HB2' HD22 ' A' ' 61' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 52' ' ' ALA . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.608 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.714 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.6 p-80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.862 0.363 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.935 HG21 ' O ' ' A' ' 58' ' ' GLY . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 80.4 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 36' ' ' TYR . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 48' ' ' MET . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 40' ' ' VAL . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' SER . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.451 ' SD ' HG22 ' A' ' 63' ' ' VAL . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.935 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.626 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 48' ' ' MET . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.5 t . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.536 HG21 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.536 ' ND2' HG21 ' A' ' 9' ' ' THR . 28.2 p30 . . . . . 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 51.8 mp0 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 3.5 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.646 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.837 ' HE2' ' HE2' ' A' ' 51' ' ' LYS . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.598 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.837 ' HE2' ' HE2' ' A' ' 48' ' ' MET . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB3' ' OE1' ' A' ' 54' ' ' GLN . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.0 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 52' ' ' ALA . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.552 ' N ' ' HB ' ' A' ' 10' ' ' THR . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 47.7 p-80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.779 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.6 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.77 0.319 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.614 HG23 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.614 ' OD1' HG23 ' A' ' 9' ' ' THR . 3.0 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 30' ' ' SER . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 36' ' ' TYR . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.844 HG12 ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 61' ' ' LEU . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.844 ' OD1' HG12 ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.9 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.832 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.612 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' HD11 ' A' ' 61' ' ' LEU . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.082 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.5 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 21' ' ' VAL . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.561 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.817 HG12 ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.819 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.817 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 52' ' ' ALA . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 1.082 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.646 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.819 HG13 ' CE ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 66' ' ' GLU . 15.1 t . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.635 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.525 HG23 ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.525 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.3 m120 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.54 HG23 HG12 ' A' ' 40' ' ' VAL . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 6' ' ' SER . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 6.8 m120 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 52' ' ' ALA . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' HD11 ' A' ' 55' ' ' LEU . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.623 ' HB3' HG22 ' A' ' 3' ' ' THR . 53.5 tp10 . . . . . 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.499 HD22 ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.536 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 40' ' ' VAL . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 52' ' ' ALA . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.742 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.635 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.0 p-80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 . . . . . 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.92 0.39 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.813 ' O ' HD13 ' A' ' 7' ' ' ILE . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.696 HG23 HD22 ' A' ' 11' ' ' ASN . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.788 HG23 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.696 HD22 HG23 ' A' ' 9' ' ' THR . 69.0 m-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.663 0.268 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.642 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 29' ' ' ASP . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 61' ' ' LEU . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 52' ' ' ALA . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.788 ' CD1' HG23 ' A' ' 10' ' ' THR . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 51' ' ' LYS . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' A' ' 27' ' ' PHE . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.764 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.447 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.546 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.428 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG12 ' CE ' ' A' ' 48' ' ' MET . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.718 ' CE ' HG12 ' A' ' 44' ' ' VAL . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.663 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.764 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 36' ' ' TYR . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.778 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' PRO . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.755 HG12 ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 1.009 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.755 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HB2' HD22 ' A' ' 61' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.767 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 52' ' ' ALA . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.722 ' O ' HG21 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.571 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' A' ' 51' ' ' LYS . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.009 HG13 ' CE ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.447 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 99.0 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.647 0.26 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 45' ' ' VAL . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 40' ' ' VAL . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 1.093 ' CE ' HG22 ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.565 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 51' ' ' LYS . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HE1' ' A' ' 20' ' ' TYR . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.093 HG22 ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.7 p-80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 120.77 0.319 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.872 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.603 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.97 0.414 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 45' ' ' VAL . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.658 ' HA ' HG12 ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 27' ' ' PHE . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.598 ' ND2' HG22 ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.872 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.738 ' HD1' ' HG1' ' A' ' 10' ' ' THR . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG22 ' SD ' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.495 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.552 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 121.107 0.479 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 44' ' ' VAL . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.898 ' OG ' HD11 ' A' ' 61' ' ' LEU . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.577 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' N ' HG23 ' A' ' 7' ' ' ILE . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 4' ' ' PHE . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 40' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.68 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.898 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.533 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.0 t . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.613 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.912 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.672 ' HB3' HG21 ' A' ' 45' ' ' VAL . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.66 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CD2' ' NE2' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 32' ' ' TYR . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HG3' ' HE3' ' A' ' 48' ' ' MET . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.634 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 52' ' ' ALA . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.912 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD21 ' SD ' ' A' ' 48' ' ' MET . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.664 ' NE2' ' CD2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.9 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.535 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.946 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 p-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.472 HG12 ' ND2' ' A' ' 49' ' ' ASN . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.644 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.946 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.698 0.285 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 9.8 mp0 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 45' ' ' VAL . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 29' ' ' ASP . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.913 ' HE1' HG21 ' A' ' 63' ' ' VAL . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 52' ' ' ALA . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.55 ' N ' ' HB ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 61' ' ' LEU . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.913 HG21 ' HE1' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 55.7 p-80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.476 ' ND2' ' CG2' ' A' ' 9' ' ' THR . 81.9 m-20 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' A' ' 20' ' ' TYR . 47.3 mt-10 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.626 HG13 ' OE1' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.626 ' OE1' HG13 ' A' ' 21' ' ' VAL . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CD1' HG23 ' A' ' 45' ' ' VAL . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 34' ' ' GLU . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.557 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 27' ' ' PHE . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.581 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.902 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.902 HD12 ' HA ' ' A' ' 52' ' ' ALA . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 55' ' ' LEU . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.2 OUTLIER -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 54.2 p-80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.511 0.196 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.938 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 10' ' ' THR . 35.3 m120 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.63 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HE1' ' A' ' 36' ' ' TYR . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 4' ' ' PHE . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.822 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.64 ' HD3' ' HE1' ' A' ' 48' ' ' MET . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 15.8 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.938 ' O ' HG21 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.702 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.822 HG22 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.027 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 36' ' ' TYR . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' HD1' ' A' ' 27' ' ' PHE . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.853 ' SD ' HG22 ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.954 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' A' ' 52' ' ' ALA . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 1.027 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.853 HG22 ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.6 p30 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 45' ' ' VAL . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 39' ' ' SER . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.919 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 52' ' ' ALA . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 12.2 t -116.2 150.98 36.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 66' ' ' GLU . 52.6 m -90.44 126.98 36.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.44 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 97.6 m-85 -107.36 137.83 44.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.5 p -128.4 153.35 47.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 87.7 p -155.29 157.53 37.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.8 pt -146.26 160.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.77 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.3 t -94.12 104.36 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.776 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.2 t -153.55 153.52 32.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.628 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -133.27 93.81 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.943 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.598 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.5 p-10 -161.83 44.5 0.14 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.679 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 33.1 Cg_endo -66.1 109.72 1.59 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.391 2.061 . . . . 0.0 112.124 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD2' ' C ' ' A' ' 13' ' ' ASP . 54.1 p30 -94.09 167.9 11.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.2 -14.21 16.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.099 0.476 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.52 -39.19 97.0 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.989 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.95 -166.55 17.82 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 53.0 p90 -110.73 113.3 25.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.542 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 78.7 mm-40 -155.08 140.78 18.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.188 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.907 ' HD1' ' HH ' ' A' ' 32' ' ' TYR . 69.8 t80 -115.03 130.35 56.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 95.8 m-85 -132.26 144.45 50.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 98.9 t -93.58 119.6 41.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 51.3 mp0 -72.27 141.61 48.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.87 125.35 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.807 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.0 6.81 88.98 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -100.9 129.14 46.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 0.0 110.767 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -75.62 128.84 36.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.705 ' CZ ' ' CE2' ' A' ' 32' ' ' TYR . 86.4 t80 -70.32 127.23 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.659 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -88.65 100.07 12.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.859 ' HB3' HG21 ' A' ' 45' ' ' VAL . 56.4 p30 -70.41 -27.4 64.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.114 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.4 m -64.6 -41.46 96.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.879 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -62.67 -38.7 91.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.093 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.907 ' HH ' ' HD1' ' A' ' 19' ' ' PHE . 3.7 m-85 -59.37 -37.28 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.5 -41.53 98.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.859 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.54 -21.62 26.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.633 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -89.81 -22.94 21.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 89.8 m-85 -124.97 -7.43 7.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.547 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 63.95 28.39 72.69 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -132.47 158.95 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -83.69 124.92 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.601 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 32' ' ' TYR . 57.3 t -107.6 114.48 60.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.19 145.11 59.39 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.716 2.278 . . . . 0.0 112.207 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.6 p -62.82 -30.83 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.53 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.16 -41.48 92.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.388 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.22 -41.96 78.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.4 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.2 t -62.63 -42.76 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.064 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 25.3 pt-20 -59.36 -40.27 85.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.717 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.6 mt-10 -60.44 -41.09 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.297 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -65.01 -40.16 94.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.37 -39.75 94.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.38 97.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.62 ' HB2' HD22 ' A' ' 61' ' ' LEU . 74.1 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.7 -36.47 78.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.901 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.65 83.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -85.09 -11.47 55.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 52' ' ' ALA . 63.9 mt -72.22 134.66 45.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.14 0.495 . . . . 0.0 111.475 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -94.67 169.26 10.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.043 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.6 t0 -59.82 141.57 55.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.608 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.72 11.04 78.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.1 mt-10 -126.85 149.71 49.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.783 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 22' ' ' GLU . 54.8 m95 -138.69 151.38 47.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.714 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.1 tp -104.73 140.41 38.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.585 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -97.26 122.67 40.54 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' OH ' ' A' ' 32' ' ' TYR . 89.2 t -117.13 127.91 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.0 p -154.43 172.65 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.064 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.6 p-80 -139.84 159.81 41.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.268 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.567 ' O ' ' OG1' ' A' ' 2' ' ' THR . 89.0 tt0 -140.47 134.06 30.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.587 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.8 p -76.49 153.35 35.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.8 m -117.08 128.72 55.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 99.4 m-85 -107.68 138.54 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.58 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t -137.94 158.9 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.196 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 90.5 p -153.68 163.12 40.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.386 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 tt -153.27 156.96 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.126 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.69 105.08 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.272 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -153.35 148.49 26.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.78 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.935 HG21 ' O ' ' A' ' 58' ' ' GLY . 2.0 t -135.98 92.23 2.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.771 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.602 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 27.3 p30 -161.77 44.08 0.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.998 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 40.9 Cg_endo -69.39 110.03 2.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.391 2.061 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 14' ' ' PHE . 37.6 t70 -83.7 120.93 26.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 11.2 m-30 70.57 -25.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 65.96 35.87 91.29 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -35.3 -97.42 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.647 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 25.5 p90 -129.33 95.73 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -155.26 144.49 20.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.943 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 50.8 t80 -107.84 122.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.967 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 62' ' ' ASN . 22.3 m-85 -128.97 141.87 51.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 83.0 t -97.01 120.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.378 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.3 mp0 -70.33 145.56 51.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.77 126.38 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.693 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.36 14.1 82.25 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 11.4 tp-100 -108.13 131.02 55.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 110.707 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.14 149.41 47.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.814 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE1' ' CE2' ' A' ' 19' ' ' PHE . 91.6 t80 -89.1 120.6 30.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.24 109.82 20.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.558 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.6 p30 -73.25 -24.1 60.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.085 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.558 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.3 m -64.52 -43.62 93.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.076 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.3 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.698 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 78.1 t80 -60.76 -49.05 79.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.498 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -70.13 -28.41 65.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.132 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.79 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.665 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.71 -44.51 10.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 110.49 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 80.2 m-85 -75.37 -26.86 58.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.456 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.11 16.22 80.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 36' ' ' TYR . 31.2 m -133.14 138.31 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.227 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -65.02 147.32 53.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.819 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.1 t -107.32 119.28 51.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.319 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.99 136.82 74.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.499 2.132 . . . . 0.0 111.601 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.2 p -60.34 -33.6 72.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.82 96.96 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.147 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 48' ' ' MET . 70.7 t -68.18 -42.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.145 0.498 . . . . 0.0 110.373 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 40' ' ' VAL . 58.5 t -61.81 -41.84 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.615 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' SER . 80.4 mm-40 -60.87 -43.85 97.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -40.34 95.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.451 ' SD ' HG22 ' A' ' 63' ' ' VAL . 26.3 mmt -64.77 -40.2 94.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.204 0.526 . . . . 0.0 109.754 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.6 -38.81 90.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.2 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.62 97.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.617 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 74.3 mmtt -62.29 -40.7 97.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.25 -37.43 83.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.79 86.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -83.61 -19.21 35.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 76.1 mt -73.36 136.86 44.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.767 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.66 166.95 11.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.4 p30 -58.34 154.73 13.0 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.729 -0.389 . . . . 0.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.935 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.46 8.89 86.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 53.4 mt-10 -130.6 153.86 48.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.092 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.626 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 50.4 m95 -137.31 149.43 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.157 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 53.7 tp -96.73 141.5 29.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 25.1 t-20 -104.5 120.08 40.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.776 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 48' ' ' MET . 82.9 t -115.93 126.12 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.003 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -152.58 177.64 10.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.284 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.3 p-80 -141.41 161.5 37.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.275 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' THR . 89.0 tt0 -118.32 135.12 54.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.557 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.14 130.94 57.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.507 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.5 t -126.87 145.8 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.742 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 95.8 m-85 -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.357 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 p -129.27 153.64 47.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.641 ' OG ' ' SD ' ' A' ' 48' ' ' MET . 60.0 m -137.75 149.3 46.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 90.4 mt -139.45 142.83 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -86.09 104.92 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.01 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.536 HG21 ' ND2' ' A' ' 11' ' ' ASN . 0.7 OUTLIER -153.02 148.21 26.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.833 178.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -123.93 92.48 3.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.17 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.545 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 28.2 p30 -141.01 59.19 10.39 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.291 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 56.9 Cg_exo -51.02 118.53 4.34 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -125.74 135.95 52.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.0 -10.52 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.307 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.76 -39.4 96.67 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.78 -170.37 14.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.638 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.2 p90 -96.34 115.9 28.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.8 mp0 -154.83 140.31 17.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.385 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 27' ' ' PHE . 66.0 t80 -114.16 126.93 55.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . 90.8 m-85 -126.84 138.92 53.41 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 89.8 t -98.37 119.88 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.304 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -67.07 139.27 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.744 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.44 126.79 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.728 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.33 82.1 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.8 tp-100 -108.51 134.18 51.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.787 0.327 . . . . 0.0 110.713 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLN . 3.5 mp0 -67.75 151.91 46.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.039 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 90.2 t80 -96.24 123.33 39.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.549 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -86.03 99.5 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.883 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.646 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.0 p30 -68.28 -26.32 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 75.2 m -64.26 -45.18 89.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.808 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.3 94.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 58.3 t80 -61.94 -48.61 79.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.44 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.61 -37.93 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.281 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 89.0 tt0 -60.9 -48.38 82.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.35 80.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.8 m-85 -82.16 -16.7 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.58 17.1 80.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.8 m -129.13 136.36 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -62.89 143.64 57.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.323 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -110.69 122.24 38.83 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.268 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 44.0 Cg_endo -67.56 146.22 73.1 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.9 m -60.97 -36.87 80.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.432 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.86 -41.05 86.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.1 t -70.17 -43.84 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.112 0.482 . . . . 0.0 110.29 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 29' ' ' ASP . 60.5 t -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.195 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -62.31 -43.73 98.14 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.68 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -60.18 -43.72 95.65 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.193 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.837 ' HE2' ' HE2' ' A' ' 51' ' ' LYS . 38.7 mmt -64.16 -40.07 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -65.83 -38.72 89.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.657 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.598 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.35 -43.43 98.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.95 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.837 ' HE2' ' HE2' ' A' ' 48' ' ' MET . 57.5 mtmt -61.92 -40.7 96.39 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.69 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.1 -35.81 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.996 0.427 . . . . 0.0 110.199 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB3' ' OE1' ' A' ' 54' ' ' GLN . . . -61.41 -37.66 84.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.736 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.0 mp0 -87.23 -13.75 42.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 52' ' ' ALA . 74.0 mt -74.03 139.05 44.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 111.267 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.99 167.24 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.044 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -58.67 154.65 14.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.13 12.86 82.8 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -130.5 149.78 52.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.552 ' N ' ' HB ' ' A' ' 10' ' ' THR . 94.9 m95 -137.44 149.47 46.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 48' ' ' MET . 54.0 tp -99.26 137.84 37.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -109.91 122.29 47.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.824 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.19 125.56 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.375 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -137.35 171.37 14.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.964 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 47.7 p-80 -144.03 160.86 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.779 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.6 tt0 -105.88 129.99 53.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.791 0.329 . . . . 0.0 110.478 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.62 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.6 m -72.3 132.76 44.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.698 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -118.57 129.76 55.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.8 m-85 -107.15 136.92 46.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.557 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.8 p -130.35 158.49 39.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.2 p -155.97 161.71 40.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.1 tp -148.72 157.53 7.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.61 104.53 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.614 HG23 ' OD1' ' A' ' 11' ' ' ASN . 4.9 t -153.83 157.47 39.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.66 91.89 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.558 178.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.614 ' OD1' HG23 ' A' ' 9' ' ' THR . 3.0 p-10 -144.12 63.13 11.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.6 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 10.3 Cg_endo -54.0 117.52 3.97 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.804 2.336 . . . . 0.0 111.531 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -110.49 100.91 9.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.717 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.8 -33.68 72.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.65 -23.59 63.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.741 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.82 -173.62 16.3 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.6 p90 -105.59 115.74 30.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.15 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.7 mt-10 -154.98 140.94 18.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 58.0 t80 -111.67 127.24 55.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.126 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 94.2 m-85 -130.39 141.75 50.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 90.1 t -96.46 121.72 47.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.146 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 98.6 mt-10 -69.2 140.53 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.13 127.49 12.55 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.738 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.6 14.56 81.09 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.81 131.79 54.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.491 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -75.01 123.43 25.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 0.0 110.858 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 82.5 t80 -59.02 122.65 14.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 30' ' ' SER . 66.9 t0 -91.16 102.75 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 57.1 p30 -72.36 -15.63 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.61 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 48.4 t -63.3 -47.0 84.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.46 94.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 83.4 t80 -60.25 -47.8 84.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.727 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 30' ' ' SER . 2.4 pp20? -69.53 -31.36 69.53 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.794 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 30' ' ' SER . 71.4 mm-40 -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.04 -47.07 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.436 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 83.4 m-85 -75.07 -27.78 60.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.57 14.67 81.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 36' ' ' TYR . 29.3 m -134.32 138.97 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.03 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 83.5 p -67.73 151.31 47.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.2 t -104.75 119.65 52.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.09 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.63 137.31 73.43 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.578 2.185 . . . . 0.0 112.127 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.7 t -59.13 -40.6 85.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.367 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.21 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.206 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.68 -43.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 110.079 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.844 HG12 ' OD1' ' A' ' 49' ' ' ASN . 61.5 t -63.08 -40.69 90.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.353 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.65 -46.46 90.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.331 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.03 -41.49 96.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 61' ' ' LEU . 25.7 mmt -65.13 -40.17 94.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.844 ' OD1' HG12 ' A' ' 45' ' ' VAL . 31.8 m120 -63.12 -41.08 99.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.107 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -63.48 -42.34 98.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.691 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.6 mtmt -63.37 -40.98 98.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.986 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.23 -37.31 82.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 110.724 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.31 79.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 2.9 mp0 -84.62 -18.13 36.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.1 mt -70.68 136.92 49.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 111.396 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.94 171.66 8.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.348 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 150.03 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.217 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.832 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.47 15.73 77.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.7 mt-10 -126.43 145.26 50.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.612 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.9 m95 -130.84 140.8 50.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.3 tp -98.18 137.33 37.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -104.23 126.7 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.913 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.96 127.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.988 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.1 p -154.33 172.87 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 50.3 p-80 -143.25 161.53 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.442 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.14 132.68 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.554 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mmm . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -74.37 152.9 39.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 40.3 p -120.58 147.01 45.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.561 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 87.8 m-85 -115.36 137.1 52.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.961 0.41 . . . . 0.0 110.633 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.4 m -122.87 132.94 54.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.82 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' HD11 ' A' ' 61' ' ' LEU . 45.8 t -140.53 145.33 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.469 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.1 mt -138.25 149.01 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 55' ' ' LEU . 95.4 t -87.02 104.36 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.12 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -153.37 154.96 35.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.082 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -128.51 92.25 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.14 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.573 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t-20 -162.83 47.24 0.2 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.421 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 55.8 Cg_endo -72.81 109.88 2.9 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.751 2.301 . . . . 0.0 112.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -75.85 150.7 37.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.11 9.85 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.54 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.97 2.68 79.95 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.98 -176.13 21.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 55.5 p90 -101.3 117.68 35.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.5 mm-40 -155.65 142.61 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.955 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 64.2 t80 -113.65 128.88 56.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.409 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 12' ' ' PRO . 95.3 m-85 -130.43 141.03 50.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 27' ' ' PHE . 84.1 t -91.14 117.92 35.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.185 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.2 mt-10 -72.2 144.63 48.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.95 133.35 38.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.044 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.97 81.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.5 mm-40 -119.64 153.31 35.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 110.627 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -99.55 127.26 45.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 21' ' ' VAL . 89.8 t80 -61.01 128.28 35.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.541 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -93.68 111.1 22.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.25 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.6 p30 -73.67 -21.64 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 91.3 p -70.11 -41.62 73.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.64 70.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 48.9 t80 -62.79 -48.28 79.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.06 -36.13 81.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.145 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -62.14 -46.05 90.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.702 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.5 95.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.368 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.561 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 97.2 m-85 -90.64 -11.61 39.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 71.32 19.07 77.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.6 m -128.7 137.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.815 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -64.34 137.34 57.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.265 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.5 t -99.81 119.13 60.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.25 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.79 132.39 51.57 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.45 -39.39 83.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.106 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.87 -39.93 82.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.213 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.89 -41.81 88.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.817 HG12 ' OD1' ' A' ' 49' ' ' ASN . 63.0 t -62.54 -41.48 92.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.421 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 7.1 pt-20 -59.07 -43.16 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.026 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.0 tp10 -58.53 -44.67 89.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.819 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.1 mtt -64.61 -39.73 94.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.817 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.5 m120 -62.03 -41.3 97.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.076 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.75 98.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.93 -41.18 97.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.985 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.64 -37.22 80.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.62 83.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -86.22 -13.65 46.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 52' ' ' ALA . 51.1 mt -69.69 129.64 40.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.24 0.543 . . . . 0.0 111.389 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -92.9 168.29 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.0 t0 -55.68 146.06 22.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.151 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 1.082 ' O ' HG21 ' A' ' 10' ' ' THR . . . 81.72 16.04 74.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.8 mt-10 -130.99 151.04 51.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.796 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.646 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 52.4 m95 -138.39 150.3 46.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 6' ' ' SER . 52.9 tp -99.92 139.32 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.02 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 6' ' ' SER . 26.7 t-20 -106.29 128.44 53.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.038 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.819 HG13 ' CE ' ' A' ' 48' ' ' MET . 84.1 t -116.91 128.64 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.115 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 94.1 p -151.55 172.79 15.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 52.9 p-80 -143.6 161.25 39.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.2 tp10 -99.13 128.86 45.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.591 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.865 ' HG3' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.865 ' N ' ' HG3' ' A' ' 1' ' ' MET . 95.2 m -113.29 131.13 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 66' ' ' GLU . 15.1 t -128.26 147.73 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.097 0.475 . . . . 0.0 110.894 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.9 m-85 -114.96 139.99 49.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.2 p -126.47 157.89 37.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.635 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.9 t -151.42 146.8 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -139.62 147.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.99 104.19 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.559 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.525 HG23 ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -152.63 143.14 22.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.182 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -120.47 91.84 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.514 -1.274 . . . . 0.0 111.633 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.525 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.3 m120 -133.94 72.02 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.758 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 24.6 Cg_endo -63.58 111.79 1.59 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.147 1.898 . . . . 0.0 111.527 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -129.45 139.93 51.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.57 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.04 -14.31 15.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.86 96.81 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.76 -168.18 17.33 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.5 p90 -102.89 112.51 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.425 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 79.0 mm-40 -155.07 142.42 19.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.117 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' ' HE2' ' A' ' 27' ' ' PHE . 59.0 t80 -117.66 128.07 54.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.6 m-85 -124.59 136.34 53.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.807 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.61 117.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.7 tt0 -64.89 135.23 55.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.64 128.5 12.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.707 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.21 82.47 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -109.44 134.39 51.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 110.539 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.29 122.91 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 87.4 t80 -62.89 128.05 34.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.5 114.53 26.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.324 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -73.9 -23.31 59.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 90.6 p -68.28 -41.62 80.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.516 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.87 97.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.757 0.313 . . . . 0.0 111.433 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 74.2 t80 -60.4 -48.53 81.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.604 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -70.97 -24.56 62.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.08 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -61.99 -46.06 90.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.788 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.47 -43.55 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 m-85 -75.24 -27.0 59.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.451 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 17.7 79.78 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.0 m -132.09 139.42 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.182 0.515 . . . . 0.0 111.308 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.87 142.46 58.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.651 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.3 t -102.97 116.75 61.97 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.009 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.85 136.54 72.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.644 2.23 . . . . 0.0 112.139 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -59.37 -39.81 84.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.162 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' O ' ' OE1' ' A' ' 47' ' ' GLU . . . -59.46 -41.88 90.73 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.278 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.57 -42.78 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 110.086 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.54 HG23 HG12 ' A' ' 40' ' ' VAL . 57.6 t -62.45 -40.41 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.519 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.39 -45.91 91.86 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.451 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -61.26 -40.3 93.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.029 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 6' ' ' SER . 25.5 mmt -63.85 -40.1 95.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 27' ' ' PHE . 6.8 m120 -63.34 -40.35 97.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.953 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.25 99.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.736 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.0 mttp -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.49 -37.09 82.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.026 0.441 . . . . 0.0 110.808 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.52 -37.07 82.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.62 -15.86 47.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.821 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 52' ' ' ALA . 73.7 mt -71.2 134.22 46.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.271 0.558 . . . . 0.0 111.329 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -95.26 171.29 8.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.361 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.1 t0 -58.66 143.45 46.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.45 12.24 80.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.536 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -129.33 150.13 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 22' ' ' GLU . 40.6 m95 -140.45 153.7 46.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' HD11 ' A' ' 55' ' ' LEU . 55.0 tp -103.4 141.93 35.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.61 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.7 m120 -104.55 129.5 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 111.237 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 ' SD ' ' A' ' 48' ' ' MET . 83.7 t -120.48 127.69 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.269 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 26.6 t -150.0 177.2 10.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.423 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 48.7 p-80 -146.1 161.42 40.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.623 ' HB3' HG22 ' A' ' 3' ' ' THR . 53.5 tp10 -114.71 133.58 55.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.519 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 1' ' ' MET . 27.4 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.8 m -115.25 128.23 56.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.7 m -118.39 129.2 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HE1' ' CE2' ' A' ' 32' ' ' TYR . 98.0 m-85 -101.98 133.65 46.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.3 m -125.94 131.49 52.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.593 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.8 m -132.44 154.12 50.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -146.67 158.11 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.17 104.02 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.707 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.91 146.25 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.485 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -124.04 91.74 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 118.606 -1.238 . . . . 0.0 111.493 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.499 HD22 ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -144.17 60.51 8.03 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.973 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 60.4 Cg_exo -51.58 122.32 10.07 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.115 1.877 . . . . 0.0 110.922 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 15' ' ' GLY . 67.5 t0 -122.77 111.39 16.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.526 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -73.75 -25.37 60.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.459 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -59.42 -39.86 95.37 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.415 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.3 -171.16 17.13 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 50.8 p90 -100.96 114.82 29.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.195 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.7 mt-10 -155.21 141.75 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' ' CD1' ' A' ' 27' ' ' PHE . 69.7 t80 -116.63 129.5 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.521 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 96.3 m-85 -129.24 140.55 51.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 97.3 t -94.57 119.71 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 50.9 mp0 -70.76 142.23 51.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.03 127.61 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.905 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.25 13.83 82.44 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.1 tp60 -107.07 130.62 54.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.58 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -74.14 125.89 29.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.536 ' CD1' ' HE2' ' A' ' 19' ' ' PHE . 85.1 t80 -64.94 125.84 26.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.72 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -87.61 105.63 17.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.3 p30 -71.37 -27.15 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.585 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.8 m -65.08 -44.33 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.36 97.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.697 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 68.1 t80 -60.8 -48.73 80.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.0 pt-20 -68.79 -31.06 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.16 -50.35 72.2 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.864 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.39 41.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.998 0.428 . . . . 0.0 111.044 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.697 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 76.4 m-85 -76.41 -22.93 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.901 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.3 16.44 80.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.5 m -129.98 137.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.7 m -65.49 144.49 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 57.4 t -108.96 122.29 40.37 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.977 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 38.3 Cg_endo -66.32 144.92 76.07 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.567 2.178 . . . . 0.0 112.281 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.4 m -60.28 -38.04 82.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.617 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.34 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.423 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 68.4 t -67.1 -43.26 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.125 0.488 . . . . 0.0 110.06 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG23 HG12 ' A' ' 40' ' ' VAL . 59.1 t -62.75 -41.29 91.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.657 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.03 -45.04 96.42 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.472 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.82 -40.74 96.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.593 ' CE ' ' OG ' ' A' ' 6' ' ' SER . 26.3 mmt -65.4 -40.62 93.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.88 -39.01 90.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.404 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.55 -42.02 98.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.416 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.91 -41.28 97.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.17 -36.76 80.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.75 83.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -85.64 -14.07 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 52' ' ' ALA . 62.9 mt -72.77 136.2 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.312 0.577 . . . . 0.0 111.582 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -94.07 167.73 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.669 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.3 p30 -59.07 154.44 15.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.016 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.742 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.54 9.35 86.55 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.58 151.96 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 52.2 m95 -139.43 152.64 47.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 55.3 tp -99.86 140.96 33.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.4 t-20 -106.89 125.17 50.66 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.828 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.42 123.86 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 57.5 m -142.65 174.69 10.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.141 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.635 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.0 p-80 -143.33 160.69 40.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.273 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.8 tt0 -115.37 134.6 54.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.554 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 67' ' ' ALA . 62.0 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.24 128.56 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.455 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLU . 98.9 m -118.81 129.14 55.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 97.7 m-85 -100.24 134.79 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.469 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.7 m -124.97 132.84 53.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.813 ' O ' HD13 ' A' ' 7' ' ' ILE . 98.1 p -138.99 153.66 48.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 6' ' ' SER . 43.4 mm -144.93 147.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -82.35 105.68 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.141 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.696 HG23 HD22 ' A' ' 11' ' ' ASN . 0.9 OUTLIER -151.76 143.28 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.788 HG23 ' CD1' ' A' ' 60' ' ' TRP . 24.5 m -120.63 92.38 3.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 117.879 -1.529 . . . . 0.0 112.3 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.696 HD22 HG23 ' A' ' 9' ' ' THR . 69.0 m-80 -143.67 73.44 17.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.497 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.87 113.25 1.49 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.408 2.072 . . . . 0.0 111.498 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -122.9 136.56 54.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.611 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.07 -17.54 14.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 0.0 110.721 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.72 -40.3 97.87 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.92 -167.68 22.37 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 49.3 p90 -104.22 109.96 21.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.966 0.412 . . . . 0.0 110.223 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 51.0 mp0 -154.76 140.1 17.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.453 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.7 t80 -117.6 130.19 56.23 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HD2' ' O ' ' A' ' 61' ' ' LEU . 92.3 m-85 -126.04 138.0 53.69 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.542 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 89.4 t -92.75 117.71 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.973 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.609 ' CA ' ' CZ3' ' A' ' 60' ' ' TRP . 88.6 tt0 -65.84 133.05 50.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -44.04 125.77 4.56 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.766 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.49 11.48 84.79 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 57.8 tp60 -106.84 133.71 51.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.878 0.37 . . . . 0.0 110.475 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.77 126.72 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.973 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.584 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.1 t80 -66.05 128.77 37.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.661 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.05 98.47 11.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.642 ' HB3' HG21 ' A' ' 45' ' ' VAL . 57.8 p30 -72.45 -22.79 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.1 t -64.07 -48.54 75.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.1 -38.55 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.695 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 48.1 t80 -57.51 -38.49 74.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.7 mt-10 -62.0 -41.21 97.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -86.39 -18.26 32.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -83.59 -31.95 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.902 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.695 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 92.3 m-85 -122.67 -4.26 8.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.66 30.91 79.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -129.63 158.89 42.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.983 0.421 . . . . 0.0 110.992 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -84.09 123.31 29.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.63 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 58.8 t -103.76 112.4 65.56 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 56.9 Cg_endo -70.18 145.17 53.97 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.67 2.247 . . . . 0.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.5 m -60.55 -37.81 82.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -59.08 -41.97 89.32 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.472 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 41' ' ' PRO . 4.8 p -71.9 -34.32 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.618 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 29' ' ' ASP . 61.9 t -64.44 -42.18 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.183 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 8.2 pt-20 -61.27 -42.74 99.14 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.556 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 54.5 tp10 -59.29 -44.89 92.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.21 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 6' ' ' SER . 26.1 mmt -64.22 -40.61 96.41 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.91 -39.4 93.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.608 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.75 99.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 61' ' ' LEU . 58.2 mtmt -62.11 -41.3 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.59 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.32 83.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.851 0.358 . . . . 0.0 111.037 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.27 82.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.11 -12.4 58.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD12 ' HA ' ' A' ' 52' ' ' ALA . 79.2 mt -76.04 139.97 41.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 111.664 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.3 mmmt -82.38 166.09 19.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 66.8 t0 -65.6 134.01 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 10' ' ' THR . . . 97.92 13.37 43.47 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 99.7 mt-10 -122.4 148.96 44.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.788 ' CD1' HG23 ' A' ' 10' ' ' THR . 92.2 m95 -129.54 144.81 51.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.158 0.504 . . . . 0.0 110.862 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 51' ' ' LYS . 52.8 tp -104.18 145.08 30.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.1 t-20 -100.6 121.71 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.825 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' A' ' 27' ' ' PHE . 94.1 t -117.34 126.85 74.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.142 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -152.92 178.06 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.372 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 48.5 p-80 -137.43 161.4 36.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.102 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 3' ' ' THR . 88.9 tt0 -138.81 137.89 37.05 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.574 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' H3 ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.3 m -115.18 129.67 56.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.326 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' ' N ' ' A' ' 66' ' ' GLU . 96.3 m -119.02 129.36 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.007 0.432 . . . . 0.0 110.927 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 65' ' ' HIS . 98.3 m-85 -99.24 136.63 38.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.427 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.7 p -132.2 160.36 36.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 87.4 p -151.25 157.81 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.912 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.25 147.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 8' ' ' VAL . 8.6 p -80.79 104.57 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.631 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.22 146.99 25.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.547 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.764 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -122.16 91.06 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.446 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.447 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 -137.02 64.76 49.85 Favored Pre-proline 0 CA--C 1.521 -0.158 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 53.2 Cg_exo -52.69 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.241 1.961 . . . . 0.0 111.547 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -122.43 132.51 54.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.409 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.23 -21.59 13.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.592 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.25 97.28 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.91 -169.88 21.62 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 46.1 p90 -98.99 109.7 22.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.483 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 50.9 mp0 -154.99 142.28 19.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.546 ' HE1' ' CD1' ' A' ' 27' ' ' PHE . 76.8 t80 -120.39 128.34 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.605 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 94.7 m-85 -124.12 137.24 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.908 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 92.7 t -92.82 122.07 44.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.644 ' OE1' ' CH2' ' A' ' 60' ' ' TRP . 78.3 mm-40 -66.54 134.13 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.428 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -45.84 127.43 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.865 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.41 81.88 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 7.3 tm0? -110.58 136.39 49.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 110.594 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.03 127.81 33.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.186 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.715 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 83.1 t80 -62.86 125.86 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.593 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 68.0 t0 -84.91 90.35 7.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.5 p30 -70.2 -26.04 63.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.58 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 91.4 p -64.97 -39.73 93.92 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.866 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 34' ' ' GLU . . . -82.04 -32.67 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.734 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 74.2 t80 -60.14 -47.74 84.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.581 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' GLY . 25.1 pt-20 -67.54 -25.83 66.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 53.7 tp10 -60.83 -50.42 73.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.31 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.5 67.35 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.085 0.469 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.711 ' CD1' ' CE1' ' A' ' 65' ' ' HIS . 76.9 m-85 -75.87 -25.99 56.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.958 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.91 16.35 80.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.7 m -129.83 138.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.353 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.502 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 67.6 m -63.65 144.83 56.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.172 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 57.7 t -109.9 120.68 44.08 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.368 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 41.5 Cg_endo -67.58 145.22 69.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.416 2.077 . . . . 0.0 111.883 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.7 p -60.65 -33.54 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.683 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.97 96.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.446 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG12 ' CE ' ' A' ' 48' ' ' MET . 63.5 t -65.7 -43.05 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.249 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' ND2' ' A' ' 49' ' ' ASN . 58.4 t -62.1 -41.19 90.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.08 -44.96 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.14 -44.75 94.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.724 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.718 ' CE ' HG12 ' A' ' 44' ' ' VAL . 25.2 ptp -69.98 -41.5 74.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.271 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.663 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -64.59 -39.71 94.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.957 0.408 . . . . 0.0 110.337 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.73 99.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.9 mtpt -62.28 -40.16 95.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.66 -38.88 86.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.53 94.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.165 0.507 . . . . 0.0 110.038 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -73.24 -27.83 61.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.506 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -69.07 141.74 54.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.997 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.69 171.66 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.784 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 58.6 t0 -58.99 150.26 25.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.764 ' O ' HG21 ' A' ' 10' ' ' THR . . . 84.57 5.31 86.89 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 98.8 mt-10 -130.28 150.85 51.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.749 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 38.4 m95 -139.58 153.23 47.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 51' ' ' LYS . 49.1 tp -101.11 143.34 31.34 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 8.5 m120 -102.39 130.52 49.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.341 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.72 127.46 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.881 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -153.24 178.22 9.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.724 0.297 . . . . 0.0 110.482 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.711 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 48.3 p-80 -132.61 163.23 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 3' ' ' THR . 97.1 mt-10 -110.01 138.29 46.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.755 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.591 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -70.36 134.44 47.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.485 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.1 m -117.81 129.38 55.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -107.08 134.6 49.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.654 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -128.83 160.28 33.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.71 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 94.6 p -153.95 161.22 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 110.996 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.4 tp -145.29 156.44 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -99.08 103.88 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.299 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.5 t -153.43 153.19 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.384 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -128.31 93.03 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 118.034 -1.467 . . . . 0.0 112.288 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.613 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 5.6 p-10 -160.45 44.38 0.16 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.121 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.625 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 55.2 Cg_endo -70.34 112.42 3.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.641 2.228 . . . . 0.0 112.231 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.37 162.84 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.596 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -101.46 5.89 42.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.106 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.88 -39.65 98.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.66 -160.31 10.52 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 52.8 p90 -101.72 120.18 39.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 99.0 mt-10 -154.75 141.19 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.558 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 61.8 t80 -110.73 128.96 55.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.289 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.661 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 91.4 m-85 -128.16 137.18 51.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.596 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 75.1 t -86.53 117.9 31.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.366 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 88.8 tt0 -68.13 136.19 53.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.97 132.7 32.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.001 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.1 81.46 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 30.3 mm100 -120.56 151.72 39.04 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.757 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.76 122.97 34.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.149 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 86.8 t80 -56.29 127.12 29.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.563 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.51 119.4 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.257 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 59.5 p30 -81.13 -13.16 58.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.333 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 74.9 m -65.58 -45.42 83.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.835 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.6 82.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.246 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 36' ' ' TYR . 71.5 t80 -61.5 -48.5 80.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.0 pp20? -67.37 -31.82 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 89.0 tt0 -61.98 -49.45 76.03 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.1 -48.41 23.94 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.996 0.427 . . . . 0.0 111.061 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.658 ' CE1' ' CE1' ' A' ' 32' ' ' TYR . 84.7 m-85 -75.79 -25.57 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.965 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 76.0 18.35 79.52 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 36' ' ' TYR . 34.4 m -134.39 140.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.1 m -66.8 146.68 54.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.926 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.654 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 54.2 t -104.85 117.38 58.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.778 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.5 Cg_exo -55.0 137.91 77.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.712 2.274 . . . . 0.0 112.146 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 47.8 t -60.17 -40.22 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.556 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.76 89.27 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.31 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' PRO . 9.9 p -72.08 -34.98 51.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.755 HG12 ' OD1' ' A' ' 49' ' ' ASN . 69.7 t -64.79 -39.78 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.6 mm-40 -60.56 -44.23 96.38 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.783 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 54.4 tp10 -59.37 -44.34 92.74 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.619 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 1.009 ' CE ' HG13 ' A' ' 63' ' ' VAL . 64.5 mtt -63.35 -39.8 95.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.755 ' OD1' HG12 ' A' ' 45' ' ' VAL . 32.3 m120 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -63.61 -40.5 97.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.347 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HB2' HD22 ' A' ' 61' ' ' LEU . 34.4 mmtp -60.37 -40.72 91.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.128 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.767 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.9 -35.66 77.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.77 87.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 25.0 mp0 -85.47 -12.58 51.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.983 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 52' ' ' ALA . 66.4 mt -75.49 125.41 28.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 111.323 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.79 174.09 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.025 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.2 146.31 43.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.027 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.722 ' O ' HG21 ' A' ' 10' ' ' THR . . . 79.55 16.39 77.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.5 mt-10 -128.96 148.8 50.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.617 0.246 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.571 ' N ' ' HB ' ' A' ' 10' ' ' THR . 53.7 m95 -138.93 149.83 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' A' ' 51' ' ' LYS . 56.2 tp -107.29 138.73 42.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 3.1 m120 -102.81 133.82 47.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.149 0.5 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.009 HG13 ' CE ' ' A' ' 48' ' ' MET . 81.4 t -119.35 126.99 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.123 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.1 t -151.84 175.03 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.298 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 45.1 p-80 -148.27 163.02 38.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.431 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -102.22 129.58 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.714 0.292 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.575 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -80.9 153.45 27.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 32.2 p -119.74 145.53 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.643 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 96.0 m-85 -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.2 t -137.03 149.03 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.174 0.511 . . . . 0.0 111.239 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.447 ' OG ' ' CE ' ' A' ' 48' ' ' MET . 70.0 m -140.39 152.96 46.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.257 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.82 148.14 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.18 103.68 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.583 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.72 143.94 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.322 179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.03 91.8 3.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.95 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 9' ' ' THR . 34.4 m120 -135.43 71.65 66.05 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.97 113.3 1.81 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.1 1.867 . . . . 0.0 111.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 14' ' ' PHE . 58.5 t0 -131.15 139.2 49.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.506 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 98.6 m-85 -103.67 -5.26 22.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.761 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.61 95.81 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.02 -177.75 15.15 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.627 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 54.7 p90 -87.55 116.18 25.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 0.0 110.067 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 99.0 mt-10 -154.82 139.69 17.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.318 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 78.4 t80 -115.9 127.16 54.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.134 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 89.0 m-85 -124.86 137.11 54.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 94.1 t -96.94 121.18 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.5 mt-10 -69.73 140.84 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.82 126.26 10.07 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.938 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' ALA . . . 74.61 14.69 81.0 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -109.39 133.99 52.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.884 0.374 . . . . 0.0 110.716 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -62.9 161.43 12.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.733 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD2' ' CE2' ' A' ' 19' ' ' PHE . 85.7 t80 -101.01 120.33 40.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.79 82.61 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 30' ' ' SER . 53.0 p-10 -63.71 -35.1 79.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.1 t -63.15 -47.3 83.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.433 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.89 97.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' HD1' ' CG2' ' A' ' 40' ' ' VAL . 61.0 t80 -61.52 -48.86 79.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.659 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 16.3 pt-20 -67.94 -36.88 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 15.7 tm-20 -61.18 -47.65 85.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.04 82.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 82.5 m-85 -82.51 -15.99 50.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.8 15.28 80.89 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 31.4 m -127.22 135.34 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.912 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -63.2 142.42 58.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.439 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 45' ' ' VAL . 61.2 t -107.21 122.62 40.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.969 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 35.9 Cg_endo -65.47 140.28 62.59 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.348 2.032 . . . . 0.0 111.982 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 92.0 p -61.94 -34.76 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.595 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.65 -42.66 97.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.428 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' ' HG3' ' A' ' 48' ' ' MET . 67.2 t -67.5 -43.05 87.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.344 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 40' ' ' VAL . 58.0 t -60.85 -40.61 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.835 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' SER . 78.5 mm-40 -60.46 -42.79 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.566 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.63 -40.38 94.67 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.627 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 1.093 ' CE ' HG22 ' A' ' 63' ' ' VAL . 36.6 mtp -70.09 -40.25 75.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 109.895 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.556 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.3 m-20 -64.36 -38.64 91.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.797 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.05 96.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.151 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.565 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 73.9 mmtt -61.91 -41.89 98.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -62.08 -38.1 87.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.13 93.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.939 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -81.32 -22.23 38.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.6 mt -75.5 138.98 41.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.21 0.528 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -95.62 171.66 8.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.871 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.584 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 56.5 p30 -60.01 154.52 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.24 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 10' ' ' THR . . . 86.61 2.99 84.3 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' OE2' ' O ' ' A' ' 57' ' ' ASP . 53.7 mp0 -131.42 152.69 50.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.708 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 42.9 m95 -139.61 152.3 46.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 51' ' ' LYS . 53.8 tp -99.63 138.38 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HE1' ' A' ' 20' ' ' TYR . 29.7 t-20 -100.15 128.93 46.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.093 HG22 ' CE ' ' A' ' 48' ' ' MET . 61.4 t -116.71 126.28 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -153.14 176.86 11.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 110.298 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 50.7 p-80 -147.46 163.3 36.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.616 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -96.31 127.83 42.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.418 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.587 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ptp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.174 0.511 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -73.93 152.83 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.648 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.6 m -117.13 127.76 54.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.47 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 65' ' ' HIS . 90.4 m-85 -98.01 133.97 41.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.233 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.8 m -124.83 134.7 52.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 99.5 p -142.33 158.22 43.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.2 tp -150.67 158.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 7' ' ' ILE . 67.2 t -97.02 105.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.458 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 11' ' ' ASN . 5.2 t -153.47 156.77 38.79 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.872 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.72 92.3 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.752 178.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.603 ' OD1' HG23 ' A' ' 9' ' ' THR . 4.9 p-10 -155.16 56.14 1.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.484 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 92.5 Cg_exo -39.26 110.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.795 2.33 . . . . 0.0 111.725 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -112.96 133.99 54.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.621 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.85 -3.96 24.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.68 95.91 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.64 177.47 17.51 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.82 103.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.83 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 17' ' ' PHE . 98.4 mt-10 -151.24 138.16 19.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 90.1 t80 -126.51 132.26 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 97.1 m-85 -124.58 141.5 52.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 25' ' ' GLN . 85.3 t -100.93 121.96 52.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 50.4 tp10 -67.21 139.79 57.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.959 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.52 127.27 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.013 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.76 83.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.583 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 71.6 tp60 -106.14 132.28 52.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -68.31 148.9 50.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 45' ' ' VAL . 74.7 t80 -79.49 117.49 20.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.923 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' OD2' ' CE1' ' A' ' 19' ' ' PHE . 57.2 p-10 -70.58 80.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.962 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.59 ' OD2' ' N ' ' A' ' 30' ' ' SER . 51.9 p-10 -60.47 -36.93 79.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.954 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.59 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 48.4 t -63.14 -48.64 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.339 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.75 -41.47 95.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.023 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.686 ' CE2' ' CE1' ' A' ' 36' ' ' TYR . 76.1 t80 -60.54 -48.68 80.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.764 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -67.92 -30.35 69.66 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.9 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.17 -50.1 74.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.219 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.86 -46.14 63.21 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.979 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.686 ' CE1' ' CE2' ' A' ' 32' ' ' TYR . 74.3 m-85 -75.76 -24.8 56.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.722 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 78.52 15.28 81.11 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.8 m -129.78 137.92 55.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 111.269 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 68.6 m -63.73 146.74 53.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.247 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 60.4 t -106.7 115.69 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 44' ' ' VAL . 45.8 Cg_endo -68.04 149.87 77.31 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.656 2.237 . . . . 0.0 111.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.658 ' HA ' HG12 ' A' ' 45' ' ' VAL . 73.7 m -59.57 -39.54 84.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -60.94 -41.95 97.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 41' ' ' PRO . 75.0 t -71.3 -45.18 71.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.354 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 27' ' ' PHE . 8.3 p -71.88 -35.75 55.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.932 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.9 pt-20 -62.07 -43.63 98.43 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.555 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.4 mt-10 -61.17 -40.5 94.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.37 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.5 mmt -64.12 -40.47 96.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 109.957 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.598 ' ND2' HG22 ' A' ' 45' ' ' VAL . 64.4 m-80 -65.08 -39.5 93.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.374 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.77 -42.61 99.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.25 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -60.94 -40.08 91.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.302 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.96 -34.94 73.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.14 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.17 85.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.638 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 24.5 mp0 -87.43 -11.98 47.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.7 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 52' ' ' ALA . 75.9 mt -79.37 137.99 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 111.301 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HE3' ' OE1' ' A' ' 59' ' ' GLU . 23.2 pttp -103.06 176.57 5.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 58' ' ' GLY . 65.7 t0 -57.16 142.85 41.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.872 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.81 5.86 83.38 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.9 mt-10 -119.08 141.48 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.809 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.738 ' HD1' ' HG1' ' A' ' 10' ' ' THR . 97.5 m95 -131.8 142.18 49.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' SD ' ' A' ' 48' ' ' MET . 55.2 tp -99.28 138.32 36.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -102.38 122.44 44.27 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.894 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG22 ' SD ' ' A' ' 48' ' ' MET . 91.9 t -116.59 125.55 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.242 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.495 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 92.4 p -156.44 172.32 18.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.552 ' HE1' ' CD2' ' A' ' 36' ' ' TYR . 54.3 p-80 -145.66 161.6 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.628 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 3' ' ' THR . 53.6 tp10 -92.91 129.71 38.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.496 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.598 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.7 m -115.03 131.36 56.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.465 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 14.7 t -128.13 147.62 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 44' ' ' VAL . 98.1 m-85 -113.33 139.04 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.8 p -126.98 155.73 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.778 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.898 ' OG ' HD11 ' A' ' 61' ' ' LEU . 48.3 t -155.31 150.81 27.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -148.58 160.2 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' N ' HG23 ' A' ' 7' ' ' ILE . 90.5 t -101.0 104.52 16.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.924 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.534 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.05 152.61 30.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -134.81 92.32 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.373 177.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -161.22 67.72 2.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.643 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.96 109.18 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.863 2.375 . . . . 0.0 111.576 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' CG ' ' HD1' ' A' ' 14' ' ' PHE . 58.3 p30 -132.86 159.66 39.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.896 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 96.9 m-85 63.04 95.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.449 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.93 69.39 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PHE . . . -122.96 -154.24 8.99 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 50.3 p90 -86.2 107.15 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.502 . . . . 0.0 110.301 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' ' C ' ' A' ' 17' ' ' PHE . 80.4 mm-40 -154.91 141.46 18.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.671 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 85.8 t80 -125.53 131.11 52.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.579 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 94.8 m-85 -126.05 140.62 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 88.6 t -102.05 122.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.627 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 53.3 tp10 -66.57 140.36 57.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.782 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -47.94 127.49 12.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.997 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.87 81.21 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -104.94 127.37 52.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.789 0.328 . . . . 0.0 110.701 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -66.5 132.91 49.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 110.954 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.3 t80 -71.88 119.77 16.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.79 99.68 12.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.874 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.1 p30 -71.08 -22.0 62.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.555 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.512 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 89.2 p -66.94 -43.39 83.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.882 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.93 -41.72 70.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.093 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 60.9 t80 -60.93 -48.44 81.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.737 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -66.47 -32.35 73.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -49.64 76.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.064 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.51 -46.72 75.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.042 0.449 . . . . 0.0 110.891 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 74.2 m-85 -76.37 -23.21 54.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.9 18.2 79.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 34.6 m -133.96 140.51 46.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.127 0.489 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -63.3 142.94 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 45' ' ' VAL . 61.4 t -105.73 115.69 61.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.259 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 44' ' ' VAL . 52.8 Cg_exo -56.34 139.13 86.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.709 2.272 . . . . 0.0 112.324 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.2 m -60.56 -37.59 81.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.493 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -58.78 -39.99 82.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.898 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' A' ' 4' ' ' PHE . 34.7 m -76.02 -36.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.706 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 40' ' ' VAL . 59.9 t -64.29 -43.42 97.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.785 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -41.89 97.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.836 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 98.5 mt-10 -60.81 -41.57 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.164 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.68 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.3 mmt -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 0.0 109.831 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.73 -39.24 93.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.335 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.94 98.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.189 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 98.2 mttt -62.69 -40.34 96.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.56 88.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.981 0.42 . . . . 0.0 110.397 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.889 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 24.5 pt20 -80.05 -21.86 42.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 76.8 mt -77.35 139.19 39.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 111.508 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' O ' ' OE2' ' A' ' 59' ' ' GLU . 68.8 mttm -91.01 168.45 11.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.127 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 66.7 t0 -64.14 132.34 50.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.504 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 10' ' ' THR . . . 108.73 9.54 26.49 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' OE2' ' O ' ' A' ' 56' ' ' LYS . 52.6 mp0 -130.7 151.92 50.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.753 0.311 . . . . 0.0 110.381 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.627 ' CH2' ' OE2' ' A' ' 22' ' ' GLU . 98.7 m95 -131.21 141.76 50.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.636 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.898 HD11 ' OG ' ' A' ' 6' ' ' SER . 53.6 tp -99.37 141.12 32.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' SER . 29.3 t-20 -103.99 120.99 42.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.589 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 ' SD ' ' A' ' 48' ' ' MET . 69.2 t -116.54 126.63 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.134 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.533 ' HA ' ' OH ' ' A' ' 32' ' ' TYR . 95.1 p -155.09 170.91 20.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 54.0 p-80 -146.9 161.53 40.54 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.47 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -101.77 128.98 47.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.524 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.602 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.1 m -115.32 130.95 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 66' ' ' GLU . 13.0 t -126.42 147.4 49.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.673 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.613 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.1 m-85 -111.05 136.16 50.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -129.79 159.96 34.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.758 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 93.2 p -153.75 161.93 41.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 111.058 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 62' ' ' ASN . 16.3 tt -150.16 157.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.283 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.12 103.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' TRP . 7.5 t -154.0 154.1 33.13 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.912 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -129.38 91.78 3.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.243 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 34.4 m120 -146.04 45.54 0.48 Allowed Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 57.5 Cg_endo -73.26 112.6 3.57 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.633 2.222 . . . . 0.0 111.971 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -106.51 164.46 12.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -99.06 9.51 43.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.463 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.91 7.31 58.95 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.22 -177.18 24.79 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.631 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 51.4 p90 -111.23 114.62 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.005 0.431 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 51.0 mp0 -155.63 141.93 18.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CZ ' ' OD1' ' A' ' 28' ' ' ASP . 62.2 t80 -110.05 126.73 54.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.458 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 12' ' ' PRO . 97.0 m-85 -130.57 142.86 50.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.278 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 119.05 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.365 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CZ3' ' A' ' 60' ' ' TRP . 16.5 tm-20 -64.04 137.84 58.18 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' O ' ' OE1' ' A' ' 22' ' ' GLU . . . -50.28 124.21 9.97 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.633 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.77 14.36 81.08 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -115.48 147.57 40.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.072 0.436 . . . . 0.0 110.821 179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.54 152.95 33.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.289 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' CD1' ' HE1' ' A' ' 19' ' ' PHE . 88.8 t80 -90.37 122.52 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.63 ' OD1' ' CZ ' ' A' ' 19' ' ' PHE . 56.2 p30 -82.04 90.62 6.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.541 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.672 ' HB3' HG21 ' A' ' 45' ' ' VAL . 54.6 p-10 -62.38 -31.92 72.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.594 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 48.4 t -63.71 -48.33 77.5 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.537 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . . . -64.93 -41.77 95.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.66 ' CD1' HG11 ' A' ' 40' ' ' VAL . 83.4 t80 -61.12 -48.54 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.572 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.7 pt-20 -66.97 -34.53 77.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.266 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.33 -47.18 87.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.252 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.22 88.78 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.915 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CD2' ' NE2' ' A' ' 65' ' ' HIS . 97.0 m-85 -83.58 -16.44 45.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.91 17.7 80.18 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 28.2 m -132.4 137.61 54.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.197 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' OE2' ' A' ' 33' ' ' GLU . 68.4 m -71.04 149.04 46.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.951 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 32' ' ' TYR . 32.1 m -116.74 127.54 26.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.2 144.93 94.76 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.426 2.084 . . . . 0.0 111.216 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 94.8 p -59.15 -25.86 64.25 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.218 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.77 -40.64 95.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 67.7 t -67.31 -44.04 87.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.269 0.556 . . . . 0.0 110.484 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 29' ' ' ASP . 69.7 t -64.85 -41.79 93.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.935 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -61.7 -46.6 88.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.452 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HG3' ' HE3' ' A' ' 48' ' ' MET . 24.7 pt-20 -63.93 -39.21 93.64 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.708 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.634 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 39.2 mmt -67.21 -40.67 86.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.193 0.52 . . . . 0.0 109.753 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.3 m-20 -66.54 -38.47 87.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.359 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' O ' ' OE1' ' A' ' 54' ' ' GLN . . . -61.22 -41.87 97.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.647 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -60.84 -39.61 89.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.471 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.67 -34.56 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.528 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 50' ' ' ALA . 21.6 mp0 -90.89 -13.32 33.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.58 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 52' ' ' ALA . 65.1 mt -71.6 138.53 48.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.75 164.71 11.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.017 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 56.9 p30 -57.01 154.12 10.2 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.137 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.912 ' O ' HG21 ' A' ' 10' ' ' THR . . . 83.08 4.07 90.06 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.4 mt-10 -130.43 151.02 51.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.607 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 45.8 m95 -138.55 150.46 46.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.455 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD21 ' SD ' ' A' ' 48' ' ' MET . 51.9 tp -96.81 137.06 36.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.3 t-20 -106.05 123.74 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 111.025 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.52 124.35 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.24 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -138.04 168.79 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.149 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.664 ' NE2' ' CD2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -145.25 159.14 43.48 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HB3' HG22 ' A' ' 3' ' ' THR . 88.9 tt0 -106.07 127.99 53.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.503 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.539 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -115.29 128.33 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 99.3 m -118.81 129.46 55.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.039 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 65' ' ' HIS . 98.4 m-85 -105.8 135.12 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.48 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.3 p -127.86 158.08 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.535 ' OG ' HD11 ' A' ' 61' ' ' LEU . 47.4 t -155.01 150.16 27.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.892 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -139.28 157.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.2 p -100.1 103.91 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.575 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -153.39 154.11 33.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.946 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.74 93.03 3.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.012 -1.475 . . . . 0.0 112.364 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.2 p-10 -162.1 43.52 0.11 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 46.4 Cg_endo -70.39 110.13 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.454 2.103 . . . . 0.0 112.518 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.79 157.54 23.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.789 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -100.52 13.43 34.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.14 4.6 81.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.41 -178.82 30.03 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 53.6 p90 -97.38 119.11 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 51.7 mp0 -155.57 142.29 18.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE2' ' CD2' ' A' ' 27' ' ' PHE . 62.6 t80 -110.98 125.09 53.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.446 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 95.6 m-85 -129.63 141.46 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 96.6 t -96.85 120.5 46.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.122 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.3 mt-10 -69.18 144.45 53.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.55 130.63 28.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.3 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.85 15.14 81.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.7 mm-40 -118.57 147.69 43.44 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.03 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -77.19 157.52 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.634 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' OD1' ' A' ' 49' ' ' ASN . 88.5 t80 -91.9 119.6 31.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.258 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.9 99.72 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD2' ' N ' ' A' ' 30' ' ' SER . 56.9 p30 -70.53 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.268 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD2' ' A' ' 29' ' ' ASP . 74.1 m -64.67 -45.87 84.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.072 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.12 93.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' OH ' ' ND1' ' A' ' 65' ' ' HIS . 59.1 t80 -62.08 -48.62 79.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' GLY . 24.9 pt-20 -68.78 -37.07 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 88.9 tt0 -60.73 -48.04 83.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.04 84.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' CD2' ' HE1' ' A' ' 65' ' ' HIS . 74.5 m-85 -83.03 -17.12 44.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.527 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 75.44 17.97 80.02 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 26.9 m -132.1 137.62 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.22 146.24 55.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.273 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' CG2' ' HD1' ' A' ' 32' ' ' TYR . 59.3 t -107.48 119.96 49.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.515 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.11 135.85 70.6 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.545 2.163 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.3 p -61.3 -32.52 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.478 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.74 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.418 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.3 -41.6 89.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 0.0 110.255 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.472 HG12 ' ND2' ' A' ' 49' ' ' ASN . 55.4 t -61.06 -42.57 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.29 -44.73 96.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.499 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.63 -44.89 95.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.616 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.644 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.4 mmt -64.76 -40.15 94.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.94 0.4 . . . . 0.0 110.121 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.1 m-20 -64.53 -39.92 94.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.252 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -62.51 -41.92 99.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 62.6 mtpt -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.768 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.69 88.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 98.0 mm-40 -75.46 -24.35 56.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 52' ' ' ALA . 77.7 mt -70.71 138.69 50.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.326 0.584 . . . . 0.0 112.316 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.49 171.42 9.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.466 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 58' ' ' GLY . 61.1 t0 -59.75 149.27 31.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.946 ' O ' HG21 ' A' ' 10' ' ' THR . . . 85.24 10.83 77.02 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.77 151.45 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 0.0 110.824 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 46.5 m95 -137.78 148.82 45.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.266 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' SD ' ' A' ' 48' ' ' MET . 56.5 tp -100.78 137.05 39.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -106.47 129.75 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.652 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.35 129.57 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.9 p -152.01 171.77 17.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 50.2 p-80 -147.72 162.72 38.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.458 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -105.18 130.81 53.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.535 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.23 131.0 57.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 30.2 p -121.93 147.98 45.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.7 m-85 -113.42 136.49 52.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.47 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.9 m -125.05 131.75 53.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 66.7 m -126.75 150.63 48.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.422 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -141.13 156.74 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.09 104.97 15.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.5 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -152.5 141.89 21.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.308 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' N ' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -124.33 94.73 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.174 179.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.07 58.66 5.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HG3' ' NE1' ' A' ' 60' ' ' TRP . 58.6 Cg_endo -74.44 121.24 6.64 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.383 2.056 . . . . 0.0 110.751 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -131.89 166.45 21.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.997 0.427 . . . . 0.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -104.73 18.75 21.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.512 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.07 20.14 29.04 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.08 -175.56 36.58 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 40.5 p90 -121.75 110.19 15.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 110.128 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' CD ' ' O ' ' A' ' 17' ' ' PHE . 9.8 mp0 -154.93 145.87 22.59 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . 81.3 t80 -107.8 131.37 54.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.662 ' CE1' ' ND2' ' A' ' 62' ' ' ASN . 93.1 m-85 -129.13 138.47 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 27' ' ' PHE . 94.8 t -91.53 117.87 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 88.5 tt0 -70.84 134.51 47.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.69 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -42.89 126.82 3.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.63 11.17 84.34 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 52.1 tt0 -106.89 136.48 46.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.61 120.85 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.153 0.501 . . . . 0.0 110.961 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.71 ' CZ ' ' CE1' ' A' ' 32' ' ' TYR . 90.7 t80 -60.0 132.1 52.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.602 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.82 99.49 12.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 45' ' ' VAL . 58.8 p30 -75.63 -18.59 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.4 m -65.34 -43.75 89.92 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.981 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -64.56 -38.83 92.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE1' ' CZ ' ' A' ' 27' ' ' PHE . 6.2 m-85 -59.19 -37.1 76.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.172 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 99.5 mt-10 -62.46 -42.76 99.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 24.7 pt-20 -84.29 -20.59 31.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.288 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 31' ' ' ALA . . . -82.71 -33.73 27.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.405 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 65' ' ' HIS . 91.6 m-85 -121.81 -3.78 9.18 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.665 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 64.81 29.72 76.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.1 m -131.39 159.33 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.05 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.2 m -85.4 125.16 32.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 58.4 t -102.05 112.29 65.22 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.465 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.76 134.03 60.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.811 2.34 . . . . 0.0 112.571 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.3 m -60.29 -37.57 80.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.595 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.29 87.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.283 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.79 -42.21 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.285 0.564 . . . . 0.0 109.777 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 29' ' ' ASP . 63.9 t -61.66 -40.43 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.501 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.79 -46.57 88.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.336 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.05 -45.32 93.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.021 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.913 ' HE1' HG21 ' A' ' 63' ' ' VAL . 28.1 ptm -68.14 -38.67 82.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.778 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 45' ' ' VAL . 99.6 m-20 -65.4 -39.43 92.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.391 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.44 -42.83 99.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.26 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 58.1 mtmt -61.34 -41.77 97.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.359 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.44 -37.56 83.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.331 . . . . 0.0 110.885 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.82 84.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.4 -13.56 56.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.711 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 52' ' ' ALA . 68.5 mt -71.74 139.6 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.46 174.36 8.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.737 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 56.5 p30 -65.94 155.31 36.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.039 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' THR . . . 78.14 14.91 81.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -128.9 148.25 50.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.55 ' N ' ' HB ' ' A' ' 10' ' ' THR . 89.5 m95 -136.21 150.09 48.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.362 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 61' ' ' LEU . 54.8 tp -103.13 141.46 35.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.662 ' ND2' ' CE1' ' A' ' 20' ' ' TYR . 2.0 m120 -104.67 132.85 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.913 HG21 ' HE1' ' A' ' 48' ' ' MET . 82.1 t -120.68 126.73 75.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.0 m -137.86 168.92 18.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.146 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 36' ' ' TYR . 55.7 p-80 -142.52 159.43 42.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' THR . 52.9 tp10 -109.99 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.528 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.557 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 93.7 m -71.26 133.24 45.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.474 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 98.0 m -116.21 129.06 56.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 65' ' ' HIS . 98.8 m-85 -110.66 139.75 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.3 m -124.52 133.68 53.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 95.6 p -142.7 159.27 42.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -156.05 161.79 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.53 103.95 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 60' ' ' TRP . 0.9 OUTLIER -153.33 144.28 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.545 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -121.3 92.25 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.143 178.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 81.9 m-20 -134.73 62.24 52.66 Favored Pre-proline 0 CA--C 1.515 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.701 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 11' ' ' ASN . 44.2 Cg_exo -55.45 118.03 4.71 Favored 'Trans proline' 0 C--N 1.297 -2.144 0 C-N-CA 122.314 2.01 . . . . 0.0 111.168 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 55.9 p-10 -125.68 95.22 4.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.0 -36.26 83.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.12 95.81 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.53 -167.06 40.5 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 33.5 p90 -120.02 104.17 9.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.956 0.408 . . . . 0.0 109.986 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' OE2' ' OD2' ' A' ' 13' ' ' ASP . 47.3 mt-10 -155.94 146.09 21.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.821 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' HE1' ' CD2' ' A' ' 27' ' ' PHE . 83.2 t80 -111.72 128.09 55.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.404 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' OH ' ' OE1' ' A' ' 18' ' ' GLU . 79.1 m-85 -127.68 139.03 52.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.626 HG13 ' OE1' ' A' ' 25' ' ' GLN . 85.9 t -95.81 119.05 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.596 ' HA ' ' CE3' ' A' ' 60' ' ' TRP . 99.7 mt-10 -70.66 139.02 51.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.217 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.18 126.89 5.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.34 89.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.626 ' OE1' HG13 ' A' ' 21' ' ' VAL . 23.4 tm0? -102.17 133.4 47.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.598 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 3.0 pp0? -79.21 128.72 33.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CD1' HG23 ' A' ' 45' ' ' VAL . 84.0 t80 -59.45 127.03 30.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.503 . . . . 0.0 110.7 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' NE2' ' A' ' 26' ' ' GLN . 66.4 m-20 -86.19 80.57 8.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.575 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 30' ' ' SER . 57.4 p30 -69.77 -23.92 63.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.0 m -64.04 -41.5 97.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 34' ' ' GLU . . . -86.45 -21.89 26.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.535 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CE1' ' CE2' ' A' ' 36' ' ' TYR . 51.6 t80 -61.45 -36.71 81.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.68 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 mt-10 -60.97 -41.8 97.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.2 pp20? -80.35 -21.16 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 34' ' ' GLU . . . -70.8 -41.07 72.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.665 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.699 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 98.7 m-85 -119.0 -1.85 10.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.814 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 64.9 28.19 73.13 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 34.3 m -130.48 156.04 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.065 0.459 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -82.72 127.02 33.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.704 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.622 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 61.7 t -98.8 112.2 62.22 Favored Pre-proline 0 N--CA 1.456 -0.154 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.37 135.12 68.43 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.491 2.127 . . . . 0.0 111.785 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.557 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 88.8 p -56.85 -36.99 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.149 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.82 99.48 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.79 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.37 -45.67 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.354 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 27' ' ' PHE . 7.3 p -65.83 -34.95 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.4 mt-10 -61.38 -45.74 93.1 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.02 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.02 -38.92 87.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.114 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.581 ' SD ' HD21 ' A' ' 61' ' ' LEU . 39.1 mmt -61.71 -40.2 94.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 26' ' ' GLN . 65.8 m-80 -63.28 -40.43 97.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.278 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.55 99.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.283 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.7 mttm -61.27 -39.71 91.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.902 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -60.63 -38.42 84.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.08 93.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.082 0.468 . . . . 0.0 110.332 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -72.38 -25.61 61.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.667 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.902 HD12 ' HA ' ' A' ' 52' ' ' ALA . 80.1 mt -62.77 135.4 57.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.319 0.58 . . . . 0.0 111.766 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 176.69 7.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.107 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.3 116.85 16.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 110.204 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 10' ' ' THR . . . 111.49 10.2 20.03 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 99.2 mt-10 -127.96 152.21 48.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.647 ' CD1' ' CB ' ' A' ' 10' ' ' THR . 46.8 m95 -138.47 153.29 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.355 . . . . 0.0 110.533 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 55' ' ' LEU . 51.7 tp -99.52 141.11 32.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.2 OUTLIER -110.06 128.53 55.48 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.331 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.25 127.46 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 58.9 m -137.47 172.73 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 54.2 p-80 -143.29 160.39 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' ALA . 89.0 tt0 -132.89 137.62 46.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.201 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 66' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 95.0 m -115.3 130.43 56.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.486 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 39.0 p -124.39 148.18 47.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.494 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 98.5 m-85 -115.7 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.41 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -130.11 158.5 39.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.254 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 97.6 p -156.23 161.52 40.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.3 tp -148.72 156.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -98.05 104.43 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 119.869 -0.733 . . . . 0.0 111.242 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 t -153.69 153.67 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.938 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -131.02 92.98 3.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.072 -1.451 . . . . 0.0 112.387 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.621 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 35.3 m120 -158.35 43.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.44 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 11' ' ' ASN . 48.6 Cg_endo -70.91 112.26 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.574 2.183 . . . . 0.0 112.217 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -92.02 165.45 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.606 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -101.1 10.85 40.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.44 72.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.39 -178.21 28.55 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 51.7 p90 -103.92 118.43 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.964 0.411 . . . . 0.0 110.36 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 80.6 mm-40 -155.12 142.51 19.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.887 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 27' ' ' PHE . 46.9 t80 -111.96 126.45 55.15 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.5 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 94.9 m-85 -131.61 143.92 50.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG2' ' HD1' ' A' ' 27' ' ' PHE . 85.4 t -100.21 124.79 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.733 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.63 ' HG2' ' CH2' ' A' ' 60' ' ' TRP . 97.5 mt-10 -68.32 139.35 55.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 55' ' ' LEU . . . -50.91 131.13 26.39 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.19 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.31 80.86 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 99.0 mm-40 -120.12 148.64 43.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.957 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -69.41 171.22 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.071 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CE1' ' CE1' ' A' ' 19' ' ' PHE . 76.7 t80 -107.86 121.82 45.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 30' ' ' SER . 67.3 t0 -88.39 99.07 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 58.6 p30 -74.95 -15.47 60.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.917 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 28' ' ' ASP . 90.5 p -64.84 -42.82 94.61 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.41 83.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.71 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HE1' ' A' ' 36' ' ' TYR . 64.0 t80 -60.24 -48.81 80.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 pp20? -72.91 -28.19 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.295 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.17 -50.11 74.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.29 59.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.031 0.444 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CG ' ' HE1' ' A' ' 65' ' ' HIS . 20.4 m-85 -76.37 -25.1 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.161 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 74.94 21.36 78.59 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 35.3 m -130.67 140.57 48.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.196 0.522 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -65.7 145.32 56.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.165 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 29' ' ' ASP . 59.1 t -107.95 116.22 57.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.27 137.87 81.44 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.394 2.063 . . . . 0.0 111.575 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 93.0 p -59.93 -32.99 71.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.476 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.72 95.04 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.3 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 4' ' ' PHE . 66.8 t -65.9 -42.24 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.393 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.62 -39.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.587 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -44.5 93.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.327 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -40.76 92.38 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.286 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.822 ' SD ' HG22 ' A' ' 63' ' ' VAL . 39.4 mmt -64.23 -42.04 96.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 99.2 m-20 -67.04 -43.25 83.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.95 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.85 90.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.103 0.478 . . . . 0.0 110.249 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.64 ' HD3' ' HE1' ' A' ' 48' ' ' MET . 24.5 mtpp -64.11 -40.54 96.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -62.84 -37.47 86.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.13 0.49 . . . . 0.0 110.055 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.48 91.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.054 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 15.8 pt20 -78.63 -22.14 47.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 51' ' ' LYS . 77.8 mt -71.87 142.38 49.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.044 0.449 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 61.4 mtpt -93.42 171.82 8.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.197 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.57 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 99.1 m-20 -64.15 150.31 45.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.938 ' O ' HG21 ' A' ' 10' ' ' THR . . . 87.58 11.5 68.51 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 57' ' ' ASP . 60.2 mp0 -130.56 149.26 52.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.884 0.373 . . . . 0.0 110.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.63 ' CH2' ' HG2' ' A' ' 22' ' ' GLU . 98.3 m95 -130.48 140.15 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.166 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.702 HD21 ' SD ' ' A' ' 48' ' ' MET . 57.6 tp -99.12 136.53 38.95 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.4 t-20 -102.29 126.58 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.916 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.822 HG22 ' SD ' ' A' ' 48' ' ' MET . 86.7 t -117.33 127.02 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -155.45 172.76 17.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.017 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 51.0 p-80 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.392 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -89.7 128.16 36.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.329 . . . . 0.0 110.539 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.482 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.2 m -114.5 128.5 56.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.595 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.5 m -119.25 128.46 54.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.4 m-85 -101.85 134.37 45.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -138.33 160.58 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 99.9 p -150.23 158.97 44.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.172 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 pt -139.46 161.8 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.306 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.5 p -103.38 103.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.484 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 60' ' ' TRP . 2.9 t -154.13 158.02 39.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.027 HG21 ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -126.04 91.21 3.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 118.082 -1.447 . . . . 0.0 111.396 178.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -133.06 63.95 68.68 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD3' ' CD1' ' A' ' 60' ' ' TRP . 20.3 Cg_endo -61.78 114.7 2.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.552 2.168 . . . . 0.0 111.312 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.06 136.46 52.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.804 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.51 9.42 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.577 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.39 5.02 77.51 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.42 -176.61 31.68 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 52.9 p90 -102.54 118.55 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 47.6 mt-10 -155.65 142.49 18.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.943 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 54.5 t80 -111.72 127.6 55.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.699 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 18' ' ' GLU . 92.7 m-85 -128.91 139.43 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.58 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -87.01 121.61 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.332 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' OE1' ' CZ3' ' A' ' 60' ' ' TRP . 79.3 mm-40 -69.87 138.42 52.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' H ' ' HZ3' ' A' ' 60' ' ' TRP . . . -54.07 133.45 43.78 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.082 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.18 15.14 81.86 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 98.8 mm-40 -120.75 150.92 40.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.98 0.419 . . . . 0.0 110.804 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -91.11 125.12 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 19' ' ' PHE . 84.9 t80 -55.79 124.44 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 66.9 t0 -90.85 101.79 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.8 p30 -70.28 -18.75 63.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 75.6 m -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.761 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.09 93.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 36' ' ' TYR . 66.0 t80 -58.91 -42.33 89.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 37' ' ' GLY . 49.9 mt-10 -64.23 -39.6 94.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.677 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.3 -43.44 96.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.378 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.83 -47.71 8.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.71 ' CE2' ' CE2' ' A' ' 32' ' ' TYR . 87.7 m-85 -75.01 -29.9 60.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . 69.06 23.42 76.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 36' ' ' TYR . 35.1 m -130.57 148.08 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 t -66.29 130.33 42.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.863 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 58.3 t -105.74 114.77 62.55 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.238 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 44' ' ' VAL . 44.4 Cg_endo -68.54 148.23 72.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.627 2.218 . . . . 0.0 112.873 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -61.01 -37.42 82.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.951 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -56.95 -40.61 76.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' PRO . 35.9 m -77.07 -39.27 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.466 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' HD1' ' A' ' 27' ' ' PHE . 60.3 t -64.42 -42.51 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 24.8 pt-20 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.801 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 88.9 tt0 -59.82 -43.42 94.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.186 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.853 ' SD ' HG22 ' A' ' 63' ' ' VAL . 79.2 mtm -64.42 -40.15 95.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.859 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.04 -39.4 94.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.288 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' O ' ' NE2' ' A' ' 54' ' ' GLN . . . -61.68 -40.91 96.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.185 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 98.2 mttt -61.54 -39.84 92.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.954 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -59.93 -36.19 76.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.47 -37.25 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 50' ' ' ALA . 3.8 mp0 -88.57 -13.13 40.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.284 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' A' ' 52' ' ' ALA . 59.6 mt -65.85 133.84 51.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 111.512 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -95.82 169.34 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.321 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.03 142.52 46.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.244 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 1.027 ' O ' HG21 ' A' ' 10' ' ' THR . . . 82.15 16.05 72.97 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.6 mt-10 -130.68 149.41 52.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 0.0 110.757 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.654 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 47.7 m95 -139.34 151.29 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.145 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 55' ' ' LEU . 56.7 tp -97.77 134.57 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 6' ' ' SER . 29.4 t-20 -99.35 127.67 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.853 HG22 ' SD ' ' A' ' 48' ' ' MET . 71.1 t -116.47 127.04 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -154.4 171.46 19.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.204 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 36' ' ' TYR . 49.9 p-80 -144.55 161.73 38.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.07 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -84.84 124.41 31.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.712 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.4 m -115.34 130.57 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.343 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -128.16 147.8 50.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.954 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 65' ' ' HIS . 97.6 m-85 -117.15 139.88 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.49 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -129.2 156.04 44.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 91.4 p -158.37 162.73 37.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -149.61 159.83 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 79.0 t -93.05 104.54 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.092 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 60' ' ' TRP . 13.6 t -153.24 153.04 31.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.41 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.636 ' OG1' ' CD1' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -132.57 93.17 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.984 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.607 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 28.6 p30 -161.68 43.92 0.13 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HB3' ' CD1' ' A' ' 20' ' ' TYR . 37.3 Cg_endo -67.82 111.66 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.443 2.095 . . . . 0.0 112.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 54.4 p30 -91.41 167.21 12.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.692 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.04 16.0 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.722 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.36 2.89 81.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.74 -178.66 33.94 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 17' ' ' PHE . 54.6 p90 -98.24 119.72 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.011 0.434 . . . . 0.0 110.4 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 99.3 mt-10 -155.26 140.4 17.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 65.1 t80 -111.47 129.16 56.13 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.356 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 93.9 m-85 -129.76 140.49 51.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.552 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' CG2' ' HD2' ' A' ' 27' ' ' PHE . 91.3 t -91.28 118.98 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HG3' ' CZ3' ' A' ' 60' ' ' TRP . 50.9 mp0 -72.89 142.29 47.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.816 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.38 126.56 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.38 12.35 84.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 72.2 tp60 -107.16 132.32 53.16 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.558 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.61 124.12 29.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.027 0.441 . . . . 0.0 110.765 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 45' ' ' VAL . 56.8 t80 -61.33 126.95 29.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -85.86 105.89 16.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.029 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 30' ' ' SER . 55.9 p30 -70.18 -28.56 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.7 p -69.08 -40.76 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.774 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 36' ' ' TYR . 47.0 t80 -58.96 -37.82 77.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.658 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 39' ' ' SER . 99.5 mt-10 -62.2 -42.07 98.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.554 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -81.44 -27.55 34.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.316 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.93 -16.0 30.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.204 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CE1' ' CD2' ' A' ' 32' ' ' TYR . 96.7 m-85 -126.62 -11.71 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 33' ' ' GLU . . . 60.35 25.76 63.17 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.23 134.13 50.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 88.3 p -69.92 139.65 52.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.145 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.647 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 61.1 t -107.38 112.36 62.66 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.29 139.57 90.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.574 2.183 . . . . 0.0 111.396 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' HG12 ' A' ' 45' ' ' VAL . 89.6 p -58.96 -36.83 75.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.204 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.2 -42.09 98.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.27 -43.95 78.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.693 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 42' ' ' SER . 4.6 p -64.38 -35.36 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' SER . 97.9 mt-10 -62.53 -43.88 97.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.472 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 51' ' ' LYS . 54.4 tp10 -60.41 -43.84 96.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.77 -40.06 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.478 . . . . 0.0 109.799 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' CB ' ' A' ' 27' ' ' PHE . 99.2 m-20 -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.94 -42.27 98.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.548 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 68.6 mttm -61.56 -40.68 95.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.591 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.919 ' HA ' HD12 ' A' ' 55' ' ' LEU . . . -61.03 -36.05 78.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.744 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -84.0 -13.0 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 52' ' ' ALA . 78.8 mt -72.15 137.89 47.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.478 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -91.79 170.01 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.157 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.89 150.13 38.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.256 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 10' ' ' THR . . . 80.9 14.97 78.61 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 99.0 mt-10 -130.45 152.0 50.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.735 0.302 . . . . 0.0 110.823 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.636 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 53.7 m95 -137.97 150.51 47.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.695 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' TYR . 56.4 tp -104.35 140.5 37.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.666 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 6' ' ' SER . 29.3 t-20 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.781 0.324 . . . . 0.0 111.066 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.89 128.16 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.265 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.7 p -152.79 171.85 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.225 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 49.9 p-80 -146.85 161.87 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -105.77 130.3 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 179.987 . . . . . . . . 0 0 . 1 stop_ save_